26
|
Song X, Li L, Zhang X, Ma J. Comparing the efficacy and safety between femtosecond laser-assisted cataract surgery and conventional phacoemulsification cataract surgery: systematic review and meta-analysis. CANADIAN JOURNAL OF OPHTHALMOLOGY 2024:S0008-4182(24)00172-8. [PMID: 39043258 DOI: 10.1016/j.jcjo.2024.05.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 04/18/2024] [Accepted: 05/27/2024] [Indexed: 07/25/2024]
Abstract
OBJECTIVE To investigate the efficacy and safety of femtosecond laser-assisted cataract surgery (FLACS) compared with conventional phacoemulsification cataract surgery (CPCS). METHODS Randomized controlled trials (RCTs) were systematically searched in PubMed, Embase, Cochrane Library, ClinicalTrials.gov, CNKI, and Wanfang. Main outcomes were visual acuity, capsulotomy parameters, effective lens position, and complications. Secondary outcomes included refractive outcomes, intraoperative parameters, and corneal parameters. RESULTS In total, 41 RCTs involving 9310 eyes were included. There was a statistically significant difference in favour of FLACS over CPCS for uncorrected distance visual acuity at 12 months (mean difference [MD] -0.03; 95% CI -0.05 to -0.01); corrected distance visual acuity at 1 week (MD -0.05; 95% CI -0.07 to -0.02) and 12 months (MD -0.02; 95% CI -0.04 to -0.00); area of capsulotomy at 1 month (MD 4.04 mm2; 95% CI 3.45-4.64) and 6 months (MD 5.02 mm2; 95% CI 3.28-6.77); and intraocular lens centroid-pupil centroid distance at 1 week (MD -0.06 mm; 95% CI -0.08 to -0.05), 1 month (MD -0.07 mm; 95% CI -0.09 to -0.06), and 6 months (MD -0.06 mm; 95% CI -0.07 to -0.04). With regard to surgical complications, FLACS was less than CPCS for the incidence of decentred IOL (odds ratio 0.06; 95% CI 0.01-0.24). However, FLACS did not increase the incidence of other intraoperative or postoperative complications except subconjunctival hemorrhage. CONCLUSIONS Both FLACS and CPCS are effective and safe. FLACS achieves better visual outcomes in the early postoperative period and long-term follow-up, accompanied by more accurate capsulotomy and more optimized effective lens position than CPCS. However, no difference of visual outcomes was found after middle-term follow-up.
Collapse
|
27
|
Aad G, Abbott B, Abeling K, Abicht NJ, Abidi SH, Aboulhorma A, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Adam Bourdarios C, Adamczyk L, Addepalli SV, Addison MJ, Adelman J, Adiguzel A, Adye T, Affolder AA, Afik Y, Agaras MN, Agarwala J, Aggarwal A, Agheorghiesei C, Ahmad A, Ahmadov F, Ahmed WS, Ahuja S, Ai X, Aielli G, Aikot A, Ait Tamlihat M, Aitbenchikh B, Aizenberg I, Akbiyik M, Åkesson TPA, Akimov AV, Akiyama D, Akolkar NN, Aktas S, Al Khoury K, Alberghi GL, Albert J, Albicocco P, Albouy GL, Alderweireldt S, Alegria ZL, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi F, Algren M, Alhroob M, Ali B, Ali HMJ, Ali S, Alibocus SW, Aliev M, Alimonti G, Alkakhi W, Allaire C, Allbrooke BMM, Allen JF, Allendes Flores CA, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alvarez Estevez M, Alvarez Fernandez A, Alves Cardoso M, Alviggi MG, Aly M, Amaral Coutinho Y, Ambler A, Amelung C, Amerl M, Ames CG, Amidei D, Amor Dos Santos SP, Amos KR, Ananiev V, Anastopoulos C, Andeen T, Anders JK, Andrean SY, Andreazza A, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Anulli F, Aoki M, Aoki T, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Appelt C, Apyan A, Aranzabal N, Arbiol Val SJ, Arcangeletti C, Arce ATH, Arena E, Arguin JF, Argyropoulos S, Arling JH, Arnaez O, Arnold H, Artoni G, Asada H, Asai K, Asai S, Asbah NA, Assamagan K, Astalos R, Atashi S, Atkin RJ, Atkinson M, Atmani H, Atmasiddha PA, Augsten K, Auricchio S, Auriol AD, Austrup VA, Avolio G, Axiotis K, Azuelos G, Babal D, Bachacou H, Bachas K, Bachiu A, Backman F, Badea A, Baer TM, Bagnaia P, Bahmani M, Bahner D, Bailey AJ, Bailey VR, Baines JT, Baines L, Baker OK, Bakos E, Bakshi Gupta D, Balakrishnan V, Balasubramanian R, Baldin EM, Balek P, Ballabene E, Balli F, Baltes LM, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Bansal S, Barak L, Barakat M, Barberio EL, Barberis D, Barbero M, Barel MZ, Barends KN, Barillari T, Barisits MS, Barklow T, Baron P, Baron Moreno DA, Baroncelli A, Barone G, Barr AJ, Barr JD, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barros Teixeira MG, Barsov S, Bartels F, Bartoldus R, Barton AE, Bartos P, Basan A, Baselga M, Bassalat A, Basso MJ, Basson CR, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Battulga D, Bauce M, Bauer M, Bauer P, Bazzano Hurrell LT, Beacham JB, Beau T, Beaucamp JY, Beauchemin PH, Becherer F, Bechtle P, Beck HP, Becker K, Beddall AJ, Bednyakov VA, Bee CP, Beemster LJ, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beirer JF, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Benchekroun D, Bendebba F, Benhammou Y, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Bergeaas Kuutmann E, Berger N, Bergmann B, Beringer J, Bernardi G, Bernius C, Bernlochner FU, Bernon F, Berrocal Guardia A, Berry T, Berta P, Berthold A, Bertram IA, Bethke S, Betti A, Bevan AJ, Bhalla NK, Bhamjee M, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Bianco G, Biebel O, Bielski R, Biglietti M, Bindi M, Bingul A, Bini C, Biondini A, Birch-Sykes CJ, Bird GA, Birman M, Biros M, Biryukov S, Bisanz T, Bisceglie E, Biswal JP, Biswas D, Bitadze A, Bjørke K, Bloch I, Blue A, Blumenschein U, Blumenthal J, Bobbink GJ, Bobrovnikov VS, Boehler M, Boehm B, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Boonekamp M, Booth CD, Borbély AG, Bordulev IS, Borecka-Bielska HM, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Bouchhar N, Boudreau J, Bouhova-Thacker EV, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko IR, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Brener R, Brenner L, Brenner R, Bressler S, Britton D, Britzger D, Brock I, Brooijmans G, Brooks WK, Brost E, Brown LM, Bruce LE, Bruckler TL, Bruckman de Renstrom PA, Brüers B, Bruni A, Bruni G, Bruschi M, Bruscino N, Buanes T, Buat Q, Buchin D, Buckley AG, Bulekov O, Bullard BA, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burlayenko O, Burr JTP, Burton CD, Burzynski JC, Busch EL, Büscher V, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Buttinger W, Buxo Vazquez CJ, Buzykaev AR, Cabrera Urbán S, Cadamuro L, Caforio D, Cai H, Cai Y, Cai Y, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canesse A, Cantero J, Cao Y, Capocasa F, Capua M, Carbone A, Cardarelli R, Cardenas JCJ, Cardillo F, Carducci G, Carli T, Carlino G, Carlotto JI, Carlson BT, Carlson EM, Carminati L, Carnelli A, Carnesale M, Caron S, Carquin E, Carrá S, Carratta G, Carrio Argos F, Carter JWS, Carter TM, Casado MP, Caspar M, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cavaliere V, Cavalli N, Cavasinni V, Cekmecelioglu YC, Celebi E, Celli F, Centonze MS, Cepaitis V, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervato B, Cervelli A, Cesarini G, Cetin SA, Chakraborty D, Chan J, Chan WY, Chapman JD, Chapon E, Chargeishvili B, Charlton DG, Chatterjee M, Chauhan C, Chekanov S, Chekulaev SV, Chelkov GA, Chen A, Chen B, Chen B, Chen H, Chen H, Chen J, Chen J, Chen M, Chen S, Chen SJ, Chen X, Chen X, Chen Y, Cheng CL, Cheng HC, Cheong S, Cheplakov A, Cheremushkina E, Cherepanova E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalier L, Chiarella V, Chiarelli G, Chiedde N, Chiodini G, Chisholm AS, Chitan A, Chitishvili M, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow EYS, Chowdhury T, Chu KL, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Cieri D, Ciesla KM, Cindro V, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Clark A, Clark PJ, Clarry C, Clavijo Columbie JM, Clawson SE, Clement C, Clercx J, Coadou Y, Cobal M, Coccaro A, Barrue RFC, Coelho Lopes De Sa R, Coelli S, Coimbra AEC, Cole B, Collot J, Conde Muiño P, Connell MP, Connell SH, Connelly IA, Conroy EI, Conventi F, Cooke HG, Cooper-Sarkar AM, Cordeiro Oudot Choi A, Corpe LD, Corradi M, Corriveau F, Cortes-Gonzalez A, Costa MJ, Costanza F, Costanzo D, Cote BM, Cowan G, Cranmer K, Cremonini D, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosby JE, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cui Z, Cunningham WR, Curcio F, Czodrowski P, Czurylo MM, De Sousa MJDCS, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dado T, Dahbi S, Dai T, Dal Santo D, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Darmora S, Das SJ, D'Auria S, David C, Davidek T, Davis-Purcell B, Dawson I, Day-Hall HA, De K, De Asmundis R, De Biase N, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Salvo A, De Sanctis U, De Santis F, De Santo A, De Vivie De Regie JB, Dedovich DV, Degens J, Deiana AM, Del Corso F, Del Peso J, Del Rio F, Delagrange L, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delsart PA, Demers S, Demichev M, Denisov SP, D'Eramo L, Derendarz D, Derue F, Dervan P, Desch K, Deutsch C, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Domenico A, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Diaconu C, Diamantopoulou M, Dias FA, Vale TDD, Diaz MA, Diaz Capriles FG, Didenko M, Diehl EB, Diehl L, Díez Cornell S, Diez Pardos C, Dimitriadi C, Dimitrievska A, Dingfelder J, Dinu IM, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Doglioni C, Dohnalova A, Dolejsi J, Dolezal Z, Dona KM, Donadelli M, Dong B, Donini J, D'Onofrio A, D'Onofrio M, Dopke J, Doria A, Dos Santos Fernandes N, Dougan P, Dova MT, Doyle AT, Draguet MA, Dreyer E, Drivas-Koulouris I, Drnevich M, Drobac AS, Drozdova M, Du D, du Pree TA, Dubinin F, Dubovsky M, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Duden ER, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumitriu AE, Dunford M, Dungs S, Dunne K, Duperrin A, Yildiz HD, Düren M, Durglishvili A, Dwyer BL, Dyckes GI, Dyndal M, Dziedzic BS, Earnshaw ZO, Eberwein GH, Eckerova B, Eggebrecht S, Purcino De Souza EE, Ehrke LF, Eigen G, Einsweiler K, Ekelof T, Ekman PA, El Farkh S, El Ghazali Y, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Enari Y, Ene I, Epari S, Erdmann J, Erland PA, Errenst M, Escalier M, Escobar C, Etzion E, Evans G, Evans H, Evans LS, Evans MO, Ezhilov A, Ezzarqtouni S, Fabbri F, Fabbri L, Facini G, Fadeyev V, Fakhrutdinov RM, Fakoudis D, Falciano S, Falda Ulhoa Coelho LF, Falke PJ, Faltova J, Fan C, Fan Y, Fang Y, Fanti M, Faraj M, Farazpay Z, Farbin A, Farilla A, Farooque T, Farrington SM, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Federic P, Federicova P, Fedin OL, Fedotov G, Feickert M, Feligioni L, Fellers DE, Feng C, Feng M, Feng Z, Fenton MJ, Fenyuk AB, Ferencz L, Ferguson RAM, Fernandez Luengo SI, Fernandez Martinez P, Fernoux MJV, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Fiedler P, Filipčič A, Filmer EK, Filthaut F, Fiolhais MCN, Fiorini L, Fisher WC, Fitschen T, Fitzhugh PM, Fleck I, Fleischmann P, Flick T, Flores M, Flores Castillo LR, Flores Sanz De Acedo L, Follega FM, Fomin N, Foo JH, Forland BC, Formica A, Forti AC, Fortin E, Fortman AW, Foti MG, Fountas L, Fournier D, Fox H, Francavilla P, Francescato S, Franchellucci S, Franchini M, Franchino S, Francis D, Franco L, Franco Lima V, Franconi L, Franklin M, Frattari G, Freegard AC, Freund WS, Frid YY, Friend J, Fritzsche N, Froch A, Froidevaux D, Frost JA, Fu Y, Fuenzalida Garrido S, Fujimoto M, Fung KY, De Simas Filho EF, Furukawa M, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon LG, Gallas EJ, Gallop BJ, Gan KK, Ganguly S, Gao Y, Garay Walls FM, Garcia B, García C, Garcia Alonso A, Garcia Caffaro AG, García Navarro JE, Garcia-Sciveres M, Gardner GL, Gardner RW, Garelli N, Garg D, Garg RB, Gargan JM, Garner CA, Garvey CM, Gaspar P, Gassmann VK, Gaudio G, Gautam V, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gekow A, Gemme C, Genest MH, Gentile S, Gentry AD, George S, George WF, Geralis T, Gessinger-Befurt P, Geyik ME, Ghani M, Ghneimat M, Ghorbanian K, Ghosal A, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giani T, Giannetti P, Giannini A, Gibson SM, Gignac M, Gil DT, Gilbert AK, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Ginabat L, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkialas I, Gladilin LK, Glasman C, Gledhill GR, Glemža G, Glisic M, Gnesi I, Go Y, Goblirsch-Kolb M, Gocke B, Godin D, Gokturk B, Goldfarb S, Golling T, Gololo MGD, Golubkov D, Gombas JP, Gomes A, Gomes Da Silva G, Gomez Delegido AJ, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González Andana RY, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Rodrigues MV, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorini B, Gorini E, Gorišek A, Gosart TC, Goshaw AT, Gostkin MI, Goswami S, Gottardo CA, Gotz SA, Gouighri M, Goumarre V, Goussiou AG, Govender N, Grabowska-Bold I, Graham K, Gramstad E, Grancagnolo S, Grandi M, Grant CM, Gravila PM, Gravili FG, Gray HM, Greco M, Grefe C, Gregor IM, Grenier P, Grewe SG, Grieco C, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Gross E, Grosse-Knetter J, Grud C, Grundy JC, Guan L, Guan W, Gubbels C, Guerrero Rojas JGR, Guerrieri G, Guescini F, Gugel R, Guhit JAM, Guida A, Guilloton E, Guindon S, Guo F, Guo J, Guo L, Guo Y, Gupta R, Gupta R, Gurbuz S, Gurdasani SS, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta LF, Gutsche M, Gutschow C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Habedank M, Haber C, Hadavand HK, Hadef A, Hadzic S, Hagan AI, Hahn JJ, Haines EH, Haleem M, Haley J, Hall JJ, Hallewell GD, Halser L, Hamano K, Hamer M, Hamity GN, Hampshire EJ, Han J, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Hangal DA, Hanif H, Hank MD, Hankache R, Hansen JB, Hansen JD, Hansen PH, Hara K, Harada D, Harenberg T, Harkusha S, Harris ML, Harris YT, Harrison J, Harrison NM, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hauser R, Hawkes CM, Hawkings RJ, Hayashi Y, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, He F, He M, He Y, He Y, Heatley NB, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herrmann LM, Herrmann T, Herten G, Hertenberger R, Hervas L, Hesping ME, Hessey NP, Hibi H, Hill E, Hillier SJ, Hinds JR, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hitchings TG, Hiti B, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hodkinson BH, Hoecker A, Hofer DD, Hofer J, Holm T, Holzbock M, Hommels LBAH, Honan BP, Hong J, Hong TM, Hooberman BH, Hopkins WH, Horii Y, Hou S, Howard AS, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu YF, Huang S, Huang X, Huang X, Huang Y, Huang Y, Huang Z, Hubacek Z, Huebner M, Huegging F, Huffman TB, Hugli CA, Huhtinen M, Huiberts SK, Hulsken R, Huseynov N, Huston J, Huth J, Hyneman R, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Ince Lezki M, Ingebretsen Carlson T, Introzzi G, Iodice M, Ippolito V, Irwin RK, Ishino M, Islam W, Issever C, Istin S, Ito H, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jagfeld CS, Jain G, Jain P, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jessiman CE, Jézéquel S, Jia C, Jia J, Jia X, Jia X, Jia Z, Jiggins S, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Johansson P, Johns KA, Johnson JW, Jones DM, Jones E, Jones P, Jones RWL, Jones TJ, Joos HL, Joshi R, Jovicevic J, Ju X, Junggeburth JJ, Junkermann T, Juste Rozas A, Juzek MK, Kabana S, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kakati N, Kalaitzidou I, Kalderon CW, Kamenshchikov A, Kang NJ, Kar D, Karava K, Kareem MJ, Karentzos E, Karkanias I, Karkout O, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Katzy J, Kaur S, Kawade K, Kawale MP, Kawamoto C, Kawamoto T, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Ke Y, Keaveney JM, Keeler R, Kehris GV, Keller JS, Kelly AS, Kempster JJ, Kennedy KE, Kennedy PD, Kepka O, Kerridge BP, Kersten S, Kerševan BP, Keshri S, Keszeghova L, Ketabchi Haghighat S, Khan RA, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Kholodenko M, Khoo TJ, Khoriauli G, Khubua J, Khwaira YAR, Kilgallon A, Kim DW, Kim YK, Kimura N, Kingston MK, Kirchhoff A, Kirfel C, Kirfel F, Kirk J, Kiryunin AE, Kitsaki C, Kivernyk O, Klassen M, Klein C, Klein L, Klein MH, Klein M, Klein SB, Klein U, Klimek P, Klimentov A, Klioutchnikova T, Kluit P, Kluth S, Kneringer E, Knight TM, Knue A, Kobayashi R, Kobylianskii D, Koch SF, Kocian M, Kodyš P, Koeck DM, Koenig PT, Koffas T, Kolay O, Koletsou I, Komarek T, Köneke K, Kong AXY, Kono T, Konstantinidis N, Kontaxakis P, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korn S, Korolkov I, Korotkova N, Kortman B, Kortner O, Kortner S, Kostecka WH, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kovanda O, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Kramer P, Krasny MW, Krasznahorkay A, Kraus JW, Kremer JA, Kresse T, Kretzschmar J, Kreul K, Krieger P, Krishnamurthy S, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Kuchinskaia O, Kuday S, Kuehn S, Kuesters R, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kumar M, Kumari N, Kumari P, Kupco A, Kupfer T, Kupich A, Kuprash O, Kurashige H, Kurchaninov LL, Kurdysh O, Kurochkin YA, Kurova A, Kuze M, Kvam AK, Kvita J, Kwan T, Kyriacou NG, Laatu LAO, Lacasta C, Lacava F, Lacker H, Lacour D, Lad NN, Ladygin E, Laforge B, Lagouri T, Lahbabi FZ, Lai S, Lakomiec IK, Lalloue N, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lancaster AN, Lançon E, Landgraf U, Landon MPJ, Lang VS, Langenberg RJ, Langrekken OKB, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Laudrain A, Laurier A, Lawlor SD, Lawrence Z, Lazaridou R, Lazzaroni M, Le B, Le Boulicaut EM, Leban B, Lebedev A, LeBlanc M, Ledroit-Guillon F, Lee ACA, Lee SC, Lee S, Lee TF, Leeuw LL, Lefebvre HP, Lefebvre M, Leggett C, Lehmann Miotto G, Leigh M, Leight WA, Leinonen W, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewicki MP, Lewis DJ, Li A, Li B, Li C, Li CQ, Li H, Li H, Li H, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li S, Li T, Li X, Li Z, Li Z, Li Z, Liang S, Liang Z, Liberatore M, Liberti B, Lie K, Lieber Marin J, Lien H, Lin K, Lindley RE, Lindon JH, Lipeles E, Lipniacka A, Lister A, Little JD, Liu B, Liu BX, Liu D, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu Q, Liu X, Liu X, Liu Y, Liu YL, Liu YW, Llorente Merino J, Lloyd SL, Lobodzinska EM, Loch P, Lohse T, Lohwasser K, Loiacono E, Lokajicek M, Lomas JD, Long JD, Longarini I, Longo L, Longo R, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Löschcke Centeno G, Loseva O, Lou X, Lou X, Lounis A, Love J, Love PA, Lu G, Lu M, Lu S, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Lukianchuk O, Lundberg O, Lund-Jensen B, Luongo NA, Lutz MS, Lux AB, Lynn D, Lyons H, Lysak R, Lytken E, Lyubushkin V, Lyubushkina T, Lyukova MM, Ma H, Ma K, Ma LL, Ma W, Ma Y, Mac Donell DM, Maccarrone G, MacDonald JC, Machado De Abreu Farias PC, Madar R, Mader WF, Madula T, Maeda J, Maeno T, Maguire H, Maiboroda V, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Maksimovic V, Malaescu B, Malecki P, Maleev VP, Malek F, Mali M, Malito D, Mallik U, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Manco G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankad DC, Mann A, Mansoulie B, Manzoni S, Mao L, Mapekula X, Marantis A, Marchiori G, Marcisovsky M, Marcon C, Marinescu M, Marium S, Marjanovic M, Marshall EJ, Marshall Z, Marti-Garcia S, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martinez Suarez P, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Mascione D, Masetti L, Mashimo T, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Mathisen T, Matousek J, Matsuzawa N, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza M, Mazza SM, Mazzeo E, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McCracken CC, McDonald EF, McDougall AE, Mcfayden JA, McGovern RP, Mchedlidze G, Mckenzie RP, Mclachlan TC, Mclaughlin DJ, McMahon SJ, Mcpartland CM, McPherson RA, Mehlhase S, Mehta A, Melini D, Mellado Garcia BR, Melo AH, Meloni F, Mendes Jacques Da Costa AM, Meng HY, Meng L, Menke S, Mentink M, Meoni E, Mercado G, Merlassino C, Merola L, Meroni C, Merz G, Metcalfe J, Mete AS, Meyer C, Meyer JP, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Min T, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Mino Y, Mir LM, Miralles Lopez M, Mironova M, Mishima A, Missio MC, Mitra A, Mitsou VA, Mitsumori Y, Miu O, Miyagawa PS, Mkrtchyan T, Mlinarevic M, Mlinarevic T, Mlynarikova M, Mobius S, Moder P, Mogg P, Mohamed Farook MH, Mohammed AF, Mohapatra S, Mokgatitswane G, Moleri L, Mondal B, Mondal S, Mönig K, Monnier E, Monsonis Romero L, Montejo Berlingen J, Montella M, Montereali F, Monticelli F, Monzani S, Morange N, De Carvalho ALM, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern S, Morii M, Morinaga M, Morley AK, Morodei F, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Mtintsilana O, Muanza S, Mueller J, Muenstermann D, Müller R, Mullier GA, Mullin AJ, Mullin JJ, Mungo DP, Munoz Perez D, Munoz Sanchez FJ, Murin M, Murray WJ, Murrone A, Muškinja M, Mwewa C, Myagkov AG, Myers AJ, Myers G, Myska M, Nachman BP, Nackenhorst O, Nag A, Nagai K, Nagano K, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nakkalil K, Nanjo H, Narayan R, Narayanan EA, Naryshkin I, Naseri M, Nasri S, Nass C, Navarro G, Navarro-Gonzalez J, Nayak R, Nayaz A, Nechaeva PY, Nechansky F, Nedic L, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson K, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neundorf J, Newhouse R, Newman PR, Ng CW, Ng YWY, Ngair B, Nguyen HDN, Nickerson RB, Nicolaidou R, Nielsen J, Niemeyer M, Niermann J, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Ninca I, Nindhito HR, Ninio G, Nisati A, Nishu N, Nisius R, Nitschke JE, Nkadimeng EK, Nobe T, Noel DL, Nommensen T, Norfolk MB, Norisam RRB, Norman BJ, Noury M, Novak J, Novak T, Novotny L, Novotny R, Nozka L, Ntekas K, Nunes De Moura Junior NMJ, Nurse E, Ocariz J, Ochi A, Ochoa I, Oerdek S, Offermann JT, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, O'Keefe MW, Okumura Y, Seabra LFO, Olivares Pino SA, Oliveira Damazio D, Oliveira Goncalves D, Oliver JL, Öncel ÖO, O'Neill AP, Onofre A, Onyisi PUE, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Osojnak LM, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Owen M, Owen RE, Oyulmaz KY, Ozcan VE, Ozturk F, Ozturk N, Ozturk S, Pacey HA, Pacheco Pages A, Padilla Aranda C, Padovano G, Pagan Griso S, Palacino G, Palazzo A, Palestini S, Pan J, Pan T, Panchal DK, Pandini CE, Panduro Vazquez JG, Pandya HD, Pang H, Pani P, Panizzo G, Paolozzi L, Papadatos C, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Park KR, Park TH, Parker MA, Parodi F, Parrish EW, Parrish VA, Parsons JA, Parzefall U, Pascual Dias B, Pascual Dominguez L, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Patel P, Patel UM, Pater JR, Pauly T, Pearkes J, Pedersen M, Pedro R, Peleganchuk SV, Penc O, Pender EA, Penski KE, Penzin M, Peralva BS, Peixoto APP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perganti M, Perini L, Pernegger H, Perrin O, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petrukhin A, Pettee M, Pettersson NE, Petukhov A, Petukhova K, Pezoa R, Pezzotti L, Pezzullo G, Pham TM, Pham T, Phillips PW, Piacquadio G, Pianori E, Piazza F, Piegaia R, Pietreanu D, Pilkington AD, Pinamonti M, Pinfold JL, Pereira BCP, Pinto Pinoargote AE, Pintucci L, Piper KM, Pirttikoski A, Pizzi DA, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Poddar G, Poettgen R, Poggioli L, Pokharel I, Polacek S, Polesello G, Poley A, Polifka R, Polini A, Pollard CS, Pollock ZB, Polychronakos V, Pompa Pacchi E, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Poreba A, Portillo Quintero DM, Pospisil S, Postill MA, Postolache P, Potamianos K, Potepa PA, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Pozo Astigarraga ME, Prades Ibanez A, Pretel J, Price D, Primavera M, Principe Martin MA, Privara R, Procter T, Proffitt ML, Proklova N, Prokofiev K, Proto G, Protopopescu S, Proudfoot J, Przybycien M, Przygoda WW, Puddefoot JE, Pudzha D, Pyatiizbyantseva D, Qian J, Qichen D, Qin Y, Qiu T, Quadt A, Queitsch-Maitland M, Quetant G, Quinn RP, Rabanal Bolanos G, Rafanoharana D, Ragusa F, Rainbolt JL, Raine JA, Rajagopalan S, Ramakoti E, Ramirez-Berend IA, Ran K, Rapheeha NP, Rasheed H, Raskina V, Rassloff DF, Rastogi A, Rave S, Ravina B, Ravinovich I, Raymond M, Read AL, Readioff NP, Rebuzzi DM, Redlinger G, Reed AS, Reeves K, Reidelsturz JA, Reikher D, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Renner F, Rennie AG, Rescia AL, Resconi S, Ressegotti M, Rettie S, Reyes Rivera JG, Reynolds E, Rezanova OL, Reznicek P, Ribaric N, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Ridouani S, Rieck P, Riedler P, Riefel EM, Rieger JO, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Rinnagel MP, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Roberts BA, Roberts BR, Robertson SH, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Garcia Y, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roemer JT, Roepe-Gier AR, Roggel J, Røhne O, Rojas RA, Roland CPA, Roloff J, Romaniouk A, Romano E, Romano M, Romero Hernandez AC, Rompotis N, Roos L, Rosati S, Rosser BJ, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rougier C, Rousseau D, Rousso D, Roy A, Roy-Garand S, Rozanov A, Rozario ZMA, Rozen Y, Ruan X, Rubio Jimenez A, Ruby AJ, Ruelas Rivera VH, Ruggeri TA, Ruggiero A, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Russo G, Rutherfoord JP, Rutherford Colmenares S, Rybacki K, Rybar M, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sadrozinski HFW, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha S, Sahinsoy M, Saibel A, Saimpert M, Saito M, Saito T, Salamani D, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sanchez Sebastian V, Sandaker H, Sander CO, Sandesara JA, Sandhoff M, Sandoval C, Sankey DPC, Sano T, Sansoni A, Santi L, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Saraiva JG, Sardain J, Sasaki O, Sato K, Sauer C, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Scharf C, Schefer MM, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Scheulen C, Schiavi C, Schioppa EJ, Schioppa M, Schlag B, Schleicher KE, Schlenker S, Schmeing J, Schmidt MA, Schmieden K, Schmitt C, Schmitt N, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schovancova J, Schramm S, Schroeder F, Schroer T, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schuy AJ, Schwartz HR, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Selem L, Semprini-Cesari N, Sengupta D, Senthilkumar V, Serin L, Serkin L, Sessa M, Severini H, Sforza F, Sfyrla A, Shabalina E, Shaheen R, Shahinian JD, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Sharma P, Sharma S, Shatalov PB, Shaw K, Shaw SM, Shcherbakova A, Shen Q, Sheppard DJ, Sherwood P, Shi L, Shi X, Shimmin CO, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shochet MJ, Shojaii J, Shope DR, Shrestha B, Shrestha S, Shrif EM, Shroff MJ, Sicho P, Sickles AM, Sideras Haddad E, Sidoti A, Siegert F, Sijacki D, Sili F, Silva JM, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson EL, Simpson H, Simpson LR, Simpson ND, Simsek S, Sindhu S, Sinervo P, Singh S, Sinha S, Sinha S, Sioli M, Siral I, Sitnikova E, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Smakhtin V, Smart BH, Smiesko J, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith AC, Smith EA, Smith HA, Smith JL, Smith R, Smizanska M, Smolek K, Snesarev AA, Snider SR, Snoek HL, Snyder S, Sobie R, Soffer A, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Solomon S, Soloshenko A, Solovieva K, Solovyanov OV, Solovyev V, Sommer P, Sonay A, Song WY, Sonneveld JM, Sopczak A, Sopio AL, Sopkova F, Sotarriva Alvarez IR, Sothilingam V, Soto Sandoval OJ, Sottocornola S, Soualah R, Soumaimi Z, South D, Soybelman N, Spagnolo S, Spalla M, Sperlich D, Spigo G, Spinali S, Spiteri DP, Spousta M, Staats EJ, Stabile A, Stamen R, Stampekis A, Standke M, Stanecka E, Stange MV, Stanislaus B, Stanitzki MM, Stapf B, Starchenko EA, Stark GH, Stark J, Starko DM, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steentoft J, Steinberg P, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stewart JR, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Stratmann M, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su S, Su W, Su X, Sugizaki K, Sulin VV, Sullivan MJ, Sultan DMS, Sultanaliyeva L, Sultansoy S, Sumida T, Sun S, Sun S, Gudnadottir OS, Sur N, Sutton MR, Suzuki H, Svatos M, Swiatlowski M, Swirski T, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taffard A, Tafirout R, Tafoya Vargas JS, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka A, Tanaka J, Tanaka R, Tanasini M, Tao Z, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tate AC, Tateno G, Tayalati Y, Taylor GN, Taylor W, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Thaler A, Theiner O, Themistokleous N, Theveneaux-Pelzer T, Thielmann O, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Tian Y, Tikhomirov V, Tikhonov YA, Timoshenko S, Timoshyn D, Ting EXL, Tipton P, Tlou SH, Tnourji A, Todome K, Todorova-Nova S, Todt S, Togawa M, Tojo J, Tokár S, Tokushuku K, Toldaiev O, Tombs R, Tomoto M, Tompkins L, Topolnicki KW, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Tost M, Tovey DR, Traeet A, Trandafir IS, Trefzger T, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trocmé B, Troncon C, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsai M, Tsiamis A, Tsiareshka PV, Tsigaridas S, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsujikawa Y, Tsukerman II, Tsulaia V, Tsuno S, Tsuri K, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turk Cakir I, Turra R, Turtuvshin T, Tuts PM, Tzamarias S, Tzanis P, Tzovara E, Ukegawa F, Ulloa Poblete PA, Umaka EN, Unal G, Unal M, Undrus A, Unel G, Urban J, Urquijo P, Urrejola P, Usai G, Ushioda R, Usman M, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaitkus A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valiente Moreno E, Vallier A, Valls Ferrer JA, Van Arneman DR, Van Daalen TR, Van Der Graaf A, Van Gemmeren P, Van Rijnbach M, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vannoli L, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varriale L, Varvell KE, Vasile ME, Vaslin L, Vasquez GA, Vasyukov A, Vazeille F, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veliscek I, Veloce LM, Veloso F, Veneziano S, Ventura A, Ventura Gonzalez S, Verbytskyi A, Verducci M, Vergis C, Verissimo De Araujo M, Verkerke W, Vermeulen JC, Vernieri C, Vessella M, Vetterli MC, Vgenopoulos A, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Visibile A, Vittori C, Vivarelli I, Voevodina E, Vogel F, Voigt JC, Vokac P, Volkotrub Y, Von Ahnen J, Von Toerne E, Vormwald B, Vorobel V, Vorobev K, Vos M, Voss K, Vossebeld JH, Vozak M, Vozdecky L, Vranjes N, Vranjes Milosavljevic M, Vreeswijk M, Vuillermet R, Vujinovic O, Vukotic I, Wada S, Wagner C, Wagner JM, Wagner W, Wahdan S, Wahlberg H, Wakida M, Walder J, Walker R, Walkowiak W, Wall A, Wamorkar T, Wang AZ, Wang C, Wang C, Wang H, Wang J, Wang RJ, Wang R, Wang R, Wang SM, Wang S, Wang T, Wang WT, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Warburton A, Ward RJ, Warrack N, Watson AT, Watson H, Watson MF, Watton E, Watts G, Waugh BM, Weber C, Weber HA, Weber MS, Weber SM, Wei C, Wei Y, Weidberg AR, Weik EJ, Weingarten J, Weirich M, Weiser C, Wells CJ, Wenaus T, Wendland B, Wengler T, Wenke NS, Wermes N, Wessels M, Wharton AM, White AS, White A, White MJ, Whiteson D, Wickremasinghe L, Wiedenmann W, Wiel C, Wielers M, Wiglesworth C, Wilbern DJ, Wilkens HG, Williams DM, Williams HH, Williams S, Willocq S, Wilson BJ, Windischhofer PJ, Winkel FI, Winklmeier F, Winter BT, Winter JK, Wittgen M, Wobisch M, Wolffs Z, Wollrath J, Wolter MW, Wolters H, Wongel AF, Woodward EL, Worm SD, Wosiek BK, Woźniak KW, Wozniewski S, Wraight K, Wu C, Wu J, Wu M, Wu M, Wu SL, Wu X, Wu Y, Wu Z, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xia L, Xia M, Xiang J, Xie M, Xie X, Xin S, Xiong A, Xiong J, Xu D, Xu H, Xu L, Xu R, Xu T, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yamaguchi Y, Yamashita E, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan S, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye H, Ye J, Ye S, Ye X, Yeh Y, Yeletskikh I, Yeo BK, Yexley MR, Yin P, Yorita K, Younas S, Young CJS, Young C, Yu C, Yu Y, Yuan M, Yuan R, Yue L, Zaazoua M, Zabinski B, Zaid E, Zak ZK, Zakareishvili T, Zakharchuk N, Zambito S, Zamora Saa JA, Zang J, Zanzi D, Zaplatilek O, Zeitnitz C, Zeng H, Zeng JC, Zenger DT, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zhai M, Zhang B, Zhang DF, Zhang J, Zhang J, Zhang K, Zhang L, Zhang P, Zhang R, Zhang S, Zhang S, Zhang T, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao H, Zhao T, Zhao Y, Zhao Z, Zhemchugov A, Zheng J, Zheng K, Zheng X, Zheng Z, Zhong D, Zhou B, Zhou H, Zhou N, Zhou Y, Zhu CG, Zhu J, Zhu Y, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zimine NI, Zinsser J, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas TG, Zormpa O, Zou W, Zwalinski L. Statistical Combination of ATLAS Run 2 Searches for Charginos and Neutralinos at the LHC. PHYSICAL REVIEW LETTERS 2024; 133:031802. [PMID: 39094132 DOI: 10.1103/physrevlett.133.031802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Accepted: 06/07/2024] [Indexed: 08/04/2024]
Abstract
Statistical combinations of searches for charginos and neutralinos using various decay channels are performed using 139 fb^{-1} of pp collision data at sqrt[s]=13 TeV with the ATLAS detector at the Large Hadron Collider. Searches targeting pure-wino chargino pair production, pure-wino chargino-neutralino production, or Higgsino production decaying via standard model W, Z, or h bosons are combined to extend the mass reach to the produced supersymmetric particles by 30-100 GeV. The depth of the sensitivity of the original searches is also improved by the combinations, lowering the 95% C.L. cross-section upper limits by 15%-40%.
Collapse
|
28
|
Li A, Gao H, Wu H, Xie Y, Jia Z, Yang Z, Zhang Z, Zhang X. Genetic association and functional implications of TLR4 rs1927914 polymorphism on colon cancer risk. BMC Cancer 2024; 24:858. [PMID: 39026223 PMCID: PMC11256370 DOI: 10.1186/s12885-024-12604-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2024] [Accepted: 07/03/2024] [Indexed: 07/20/2024] Open
Abstract
BACKGROUND Colon cancer remains a major health concern worldwide, with genetic factors playing a crucial role in its development. Toll-like receptors (TLRs) has been implicated in various cancers, but their role in colon cancer is not well understood. This study aims to identify functional polymorphisms in the promoter and 3'UTR regions of TLRs and evaluate their association with colon cancer susceptibility. METHODS We conducted a case-control study involving 410 colon cancer patients and 410 healthy controls from the Chinese population. Genotyping of polymorphisms in TLR3, TLR4, TLR5 and TLR7 was performed using PCR-RFLP and TaqMan MGB probes. Using logistic regression analysis, we evaluated the association of TLRs polymorphisms and the susceptibility to colon cancer. To understand the biological implications of the TLR4 rs1927914 polymorphism, we conducted functional assays, including luciferase reporter assay and electrophoretic mobility shift assay (EMSA). RESULTS Our results demonstrated that the G-allele of the TLR4 rs1927914 polymorphism is significantly associated with a decreased risk of colon cancer (OR = 0.68, 95%CI = 0.50-0.91). Stratified analysis showed that TLR4 rs1927914 AG or GG genotype contributed to a decreased risk of colon cancer among younger individuals (OR = 0.52, 95%CI = 0.34-0.81), males (OR = 0.58, 95%CI = 0.38-0.87), non-smokers (OR = 0.58, 95%CI = 0.41-0.83) and non-drinker with OR (95%CI) of 0.66 (0.46-0.93). Functional assays demonstrated that in HCT116 and LOVO colon cancer cells, the luciferase activity driven by the TLR4 promoter with the rs1927914A allele was 5.43 and 2.07 times higher, respectively, compared to that driven by the promoter containing the rs1927914G allele. Electrophoretic mobility shift assay (EMSA) results indicated that the rs1927914G allele enhanced transcription factor binding. Using the transcription factor prediction tool, we found that the G allele facilitates binding of the repressive transcription factor Oct1, while the A allele does not. CONCLUSION The TLR4 rs1927914 polymorphism influence the susceptibility to colon cancer, with the G allele offering a protective effect through modulation of gene expression. These insights enhance our understanding of the genetic determinants of colon cancer risk and highlight TLR4 as a promising target for cancer prevention strategies.
Collapse
|
29
|
Cao Z, Aharonian F, Axikegu, Bai Y, Bao Y, Bastieri D, Bi X, Bi Y, Bian W, Bukevich A, Cao Q, Cao W, Cao Z, Chang J, Chang J, Chen A, Chen E, Chen H, Chen L, Chen L, Chen L, Chen M, Chen M, Chen Q, Chen S, Chen S, Chen S, Chen T, Chen Y, Cheng N, Cheng Y, Cui M, Cui S, Cui X, Cui Y, Dai B, Dai H, Dai Z, Danzengluobu, Dong X, Duan K, Fan J, Fan Y, Fang J, Fang J, Fang K, Feng C, Feng H, Feng L, Feng S, Feng X, Feng Y, Feng Y, Gabici S, Gao B, Gao C, Gao Q, Gao W, Gao W, Ge M, Geng L, Giacinti G, Gong G, Gou Q, Gu M, Guo F, Guo X, Guo Y, Guo Y, Han Y, Hasan M, He H, He H, He J, He Y, Hor Y, Hou B, Hou C, Hou X, Hu H, Hu Q, Hu S, Huang D, Huang T, Huang W, Huang X, Huang X, Huang Y, Ji X, Jia H, Jia K, Jiang K, Jiang X, Jiang Z, Jin M, Kang M, Karpikov I, Kuleshov D, Kurinov K, Li B, Li C, Li C, Li C, Li D, Li F, Li H, Li H, Li J, Li J, Li K, Li S, Li W, Li W, Li X, Li X, Li Y, Li Z, Li Z, Liang E, Liang Y, Lin S, Liu B, Liu C, Liu D, Liu D, Liu H, Liu H, Liu J, Liu J, Liu M, Liu R, Liu S, Liu W, Liu Y, Liu Y, Luo Q, Luo Y, Lv H, Ma B, Ma L, Ma X, Mao J, Min Z, Mitthumsiri W, Mu H, Nan Y, Neronov A, Ou L, Pattarakijwanich P, Pei Z, Qi J, Qi M, Qiao B, Qin J, Raza A, Ruffolo D, Sáiz A, Saeed M, Semikoz D, Shao L, Shchegolev O, Sheng X, Shu F, Song H, Stenkin Y, Stepanov V, Su Y, Sun D, Sun Q, Sun X, Sun Z, Takata J, Tam P, Tang Q, Tang R, Tang Z, Tian W, Wang C, Wang C, Wang G, Wang H, Wang H, Wang J, Wang K, Wang K, Wang L, Wang L, Wang P, Wang R, Wang W, Wang X, Wang X, Wang Y, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Wang Z, Wei D, Wei J, Wei Y, Wen T, Wu C, Wu H, Wu Q, Wu S, Wu X, Wu Y, Xi S, Xia J, Xiang G, Xiao D, Xiao G, Xin Y, Xing Y, Xiong D, Xiong Z, Xu D, Xu R, Xu R, Xu W, Xue L, Yan D, Yan J, Yan T, Yang C, Yang C, Yang F, Yang F, Yang L, Yang M, Yang R, Yang W, Yao Y, Yao Z, Yin L, Yin N, You X, You Z, Yu Y, Yuan Q, Yue H, Zeng H, Zeng T, Zeng W, Zha M, Zhang B, Zhang F, Zhang H, Zhang H, Zhang H, Zhang J, Zhang L, Zhang P, Zhang P, Zhang R, Zhang S, Zhang S, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao L, Zhao S, Zhao X, Zheng F, Zhong W, Zhou B, Zhou H, Zhou J, Zhou M, Zhou P, Zhou R, Zhou X, Zhou X, Zhu B, Zhu C, Zhu F, Zhu H, Zhu K, Zou Y, Zuo X, Celli S. Evidence for particle acceleration approaching PeV energies in the W51 complex. Sci Bull (Beijing) 2024:S2095-9273(24)00496-1. [PMID: 39153903 DOI: 10.1016/j.scib.2024.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Revised: 06/21/2024] [Accepted: 07/02/2024] [Indexed: 08/19/2024]
Abstract
The γ-ray emission from the W51 complex is widely acknowledged to be attributed to the interaction between the cosmic rays (CRs) accelerated by the shock of supernova remnant (SNR) W51C and the dense molecular clouds in the adjacent star-forming region, W51B. However, the maximum acceleration capability of W51C for CRs remains elusive. Based on observations conducted with the Large High Altitude Air Shower Observatory (LHAASO), we report a significant detection of γ rays emanating from the W51 complex, with energies from 2 to 200 TeV. The LHAASO measurements, for the first time, extend the γ-ray emission from the W51 complex beyond 100 TeV and reveal a significant spectrum bending at tens of TeV. By combining the "π0-decay bump" featured data from Fermi-LAT, the broadband γ-ray spectrum of the W51 region can be well-characterized by a simple pp-collision model. The observed spectral bending feature suggests an exponential cutoff at ∼400 TeV or a power-law break at ∼200 TeV in the CR proton spectrum, most likely providing the first evidence of SNRs serving as CR accelerators approaching the PeV regime. Additionally, two young star clusters within W51B could also be theoretically viable to produce the most energetic γ rays observed by LHAASO. Our findings strongly support the presence of extreme CR accelerators within the W51 complex and provide new insights into the origin of Galactic CRs.
Collapse
|
30
|
Xie Y, Huang C, Zhou X, Wu H, Li A, Zhang X. CD147 TagSNP is associated with the vulnerability to lung cancer in the Chinese population: a case-control study. Discov Oncol 2024; 15:281. [PMID: 39007938 PMCID: PMC11250716 DOI: 10.1007/s12672-024-01155-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2024] [Accepted: 07/11/2024] [Indexed: 07/16/2024] Open
Abstract
BACKGROUND Lung cancer, with its high morbidity and mortality, presents a major significant public health challenge. CD147, linked to cancer progression and metastasis, is a promising therapeutic target, including for lung cancer. The genetic variation may influence the expression of the gene and consequently the risk of lung cancer. This study aims to investigate single nucleotide polymorphisms (SNPs) in CD147 to understand their association with the risk of developing lung cancer in the Han Chinese population. METHODS A hospital-based case-control investigation was conducted, enrolling 700 lung cancer patients and 700 cancer-free controls. TagSNPs were selected using Haploview v4.2, and genotype data from the 1000 Genomes Project database were utilized. The selected SNPs (rs28992491, rs67945626, and rs79361899) within the CD147 gene were evaluated using the improved multiple ligation detection reaction method. Statistical analysis included chi-square tests, logistic regression models, and interaction analyses. RESULTS Baseline characteristics of the study population showed no significant differences in gender distribution between cases and controls, but there was a notable difference in smoking rates. No significant associations were found between the three TagSNPs and lung cancer susceptibility in the codominant model. However, stratification analyses revealed interesting findings. Among females, the rs79361899 AA/AG genotype was associated with an increased risk of lung cancer. In individuals aged ≥ 65 years old, the rs28992491 GG and rs79361899 AA genotypes were linked to a higher susceptibility. Furthermore, an interaction analysis demonstrated significant genotype × gender interactions in the rs79361899 recessive model, indicating an increased lung cancer risk in female carriers of the heterozygous or homozygous polymorphic genotype. CONCLUSIONS CD147 polymorphisms play an important role in lung cancer development, particularly in specific subgroup of age and gender. These findings highlight the significance of incorporating genetic variations and their interactions with demographic factors in comprehending the intricate etiology of lung cancer.
Collapse
|
31
|
Acharya S, Adamová D, Aglieri Rinella G, Agnello M, Agrawal N, Ahammed Z, Ahmad S, Ahn SU, Ahuja I, Akindinov A, Al-Turany M, Aleksandrov D, Alessandro B, Alfanda HM, Alfaro Molina R, Ali B, Alici A, Alizadehvandchali N, Alkin A, Alme J, Alocco G, Alt T, Altamura AR, Altsybeev I, Alvarado JR, Anaam MN, Andrei C, Andreou N, Andronic A, Anguelov V, Antinori F, Antonioli P, Apadula N, Aphecetche L, Appelshäuser H, Arata C, Arcelli S, Aresti M, Arnaldi R, Arneiro JGMCA, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Azmi MD, Baba H, Badalà A, Bae J, Baek YW, Bai X, Bailhache R, Bailung Y, Balbino A, Baldisseri A, Balis B, Banerjee D, Banoo Z, Barbera R, Barile F, Barioglio L, Barlou M, Barman B, Barnaföldi GG, Barnby LS, Barret V, Barreto L, Bartels C, Barth K, Bartsch E, Bastid N, Basu S, Batigne G, Battistini D, Batyunya B, Bauri D, Bazo Alba JL, Bearden IG, Beattie C, Becht P, Behera D, Belikov I, Bell Hechavarria ADC, Bellini F, Bellwied R, Belokurova S, Beltran YAV, Bencedi G, Beole S, Berdnikov Y, Berdnikova A, Bergmann L, Besoiu MG, Betev L, Bhaduri PP, Bhasin A, Bhat MA, Bhattacharjee B, Bianchi L, Bianchi N, Bielčík J, Bielčíková J, Biernat J, Bigot AP, Bilandzic A, Biro G, Biswas S, Bize N, Blair JT, Blau D, Blidaru MB, Bluhme N, Blume C, Boca G, Bock F, Bodova T, Bogdanov A, Boi S, Bok J, Boldizsár L, Bombara M, Bond PM, Bonomi G, Borel H, Borissov A, Borquez Carcamo AG, Bossi H, Botta E, Bouziani YEM, Bratrud L, Braun-Munzinger P, Bregant M, Broz M, Bruno GE, Buckland MD, Budnikov D, Buesching H, Bufalino S, Buhler P, Burmasov N, Buthelezi Z, Bylinkin A, Bysiak SA, Cai M, Caines H, Caliva A, Calvo Villar E, Camacho JMM, Camerini P, Canedo FDM, Cantway SL, Carabas M, Carballo AA, Carnesecchi F, Caron R, Carvalho LAD, Castillo Castellanos J, Catalano F, Ceballos Sanchez C, Chakaberia I, Chakraborty P, Chandra S, Chapeland S, Chartier M, Chattopadhyay S, Chattopadhyay S, Cheng T, Cheshkov C, Cheynis B, Chibante Barroso V, Chinellato DD, Chizzali ES, Cho J, Cho S, Chochula P, Choudhury D, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Ciacco M, Cicalo C, Cindolo F, Ciupek MR, Clai G, Colamaria F, Colburn JS, Colella D, Colocci M, Concas M, Conesa Balbastre G, Conesa Del Valle Z, Contin G, Contreras JG, Coquet ML, Cortese P, Cosentino MR, Costa F, Costanza S, Cot C, Crkovská J, Crochet P, Cruz-Torres R, Cui P, Dainese A, Danisch MC, Danu A, Das P, Das P, Das S, Dash AR, Dash S, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Martin C, De Pasquale S, Deb R, Del Grande R, Dello Stritto L, Deng W, Dhankher P, Di Bari D, Di Mauro A, Diab B, Diaz RA, Dietel T, Ding Y, Ditzel J, Divià R, Dixit DU, Djuvsland Ø, Dmitrieva U, Dobrin A, Dönigus B, Dubinski JM, Dubla A, Dudi S, Dupieux P, Durkac M, Dzalaiova N, Eder TM, Ehlers RJ, Eisenhut F, Ejima R, Elia D, Erazmus B, Ercolessi F, Espagnon B, Eulisse G, Evans D, Evdokimov S, Fabbietti L, Faggin M, Faivre J, Fan F, Fan W, Fantoni A, Fasel M, Feliciello A, Feofilov G, Fernández Téllez A, Ferrandi L, Ferrer MB, Ferrero A, Ferrero C, Ferretti A, Feuillard VJG, Filova V, Finogeev D, Fionda FM, Flatland E, Flor F, Flores AN, Foertsch S, Fokin I, Fokin S, Fragiacomo E, Frajna E, Fuchs U, Funicello N, Furget C, Furs A, Fusayasu T, Gaardhøje JJ, Gagliardi M, Gago AM, Gahlaut T, Galvan CD, Gangadharan DR, Ganoti P, Garabatos C, García Chávez T, Garcia-Solis E, Gargiulo C, Gasik P, Gautam A, Gay Ducati MB, Germain M, Ghimouz A, Ghosh C, Giacalone M, Gioachin G, Giubellino P, Giubilato P, Glaenzer AMC, Glässel P, Glimos E, Goh DJQ, Gonzalez V, Gordeev P, Gorgon M, Goswami K, Gotovac S, Grabski V, Graczykowski LK, Grecka E, Grelli A, Grigoras C, Grigoriev V, Grigoryan S, Grosa F, Grosse-Oetringhaus JF, Grosso R, Grund D, Grunwald NA, Guardiano GG, Guernane R, Guilbaud M, Gulbrandsen K, Gündem T, Gunji T, Guo W, Gupta A, Gupta R, Gupta R, Gwizdziel K, Gyulai L, Hadjidakis C, Haider FU, Haidlova S, Hamagaki H, Hamdi A, Han Y, Hanley BG, Hannigan R, Hansen J, Haque MR, Harris JW, Harton A, Hassan H, Hatzifotiadou D, Hauer P, Havener LB, Heckel ST, Hellbär E, Helstrup H, Hemmer M, Herman T, Herrera Corral G, Herrmann F, Herrmann S, Hetland KF, Heybeck B, Hillemanns H, Hippolyte B, Hoffmann FW, Hofman B, Hong GH, Horst M, Horzyk A, Hou Y, Hristov P, Hughes C, Huhn P, Huhta LM, Humanic TJ, Hutson A, Hutter D, Ilkaev R, Ilyas H, Inaba M, Innocenti GM, Ippolitov M, Isakov A, Isidori T, Islam MS, Ivanov M, Ivanov M, Ivanov V, Iversen KE, Jablonski M, Jacak B, Jacazio N, Jacobs PM, Jadlovska S, Jadlovsky J, Jaelani S, Jahnke C, Jakubowska MJ, Janik MA, Janson T, Ji S, Jia S, Jimenez AAP, Jonas F, Jones DM, Jowett JM, Jung J, Jung M, Junique A, Jusko A, Kaewjai J, Kalinak P, Kalteyer AS, Kalweit A, Kaplin V, Karasu Uysal A, Karatovic D, Karavichev O, Karavicheva T, Karczmarczyk P, Karpechev E, Karwowska MJ, Kebschull U, Keidel R, Keijdener DLD, Keil M, Ketzer B, Khade SS, Khan AM, Khan S, Khanzadeev A, Kharlov Y, Khatun A, Khuntia A, Kileng B, Kim B, Kim C, Kim DJ, Kim EJ, Kim J, Kim JS, Kim J, Kim J, Kim M, Kim S, Kim T, Kimura K, Kirsch S, Kisel I, Kiselev S, Kisiel A, Kitowski JP, Klay JL, Klein J, Klein S, Klein-Bösing C, Kleiner M, Klemenz T, Kluge A, Knospe AG, Kobdaj C, Kollegger T, Kondratyev A, Kondratyeva N, Kondratyuk E, Konig J, Konigstorfer SA, Konopka PJ, Kornakov G, Korwieser M, Koryciak SD, Kotliarov A, Kovalenko V, Kowalski M, Kozhuharov V, Králik I, Kravčáková A, Krcal L, Krivda M, Krizek F, Krizkova Gajdosova K, Kroesen M, Krüger M, Krupova DM, Kryshen E, Kučera V, Kuhn C, Kuijer PG, Kumaoka T, Kumar D, Kumar L, Kumar N, Kumar S, Kundu S, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kuskov V, Kweon MJ, Kwon Y, La Pointe SL, La Rocca P, Lakrathok A, Lamanna M, Landou AR, Langoy R, Larionov P, Laudi E, Lautner L, Lavicka R, Lea R, Lee H, Legrand I, Legras G, Lehrbach J, Lelek TM, Lemmon RC, León Monzón I, Lesch MM, Lesser ED, Lévai P, Li X, Lien J, Lietava R, Likmeta I, Lim B, Lim SH, Lindenstruth V, Lindner A, Lippmann C, Liu DH, Liu J, Liveraro GSS, Lofnes IM, Loizides C, Lokos S, Lömker J, Loncar P, Lopez X, López Torres E, Lu P, Lugo FV, Luhder JR, Lunardon M, Luparello G, Ma YG, Mager M, Maire A, Majerz EM, Makariev MV, Malaev M, Malfattore G, Malik NM, Malik QW, Malik SK, Malinina L, Mallick D, Mallick N, Mandaglio G, Mandal SK, Manko V, Manso F, Manzari V, Mao Y, Marcjan RW, Margagliotti GV, Margotti A, Marín A, Markert C, Martinengo P, Martínez MI, Martínez García G, Martins MPP, Masciocchi S, Masera M, Masoni A, Massacrier L, Massen O, Mastroserio A, Matonoha O, Mattiazzo S, Matyja A, Mayer C, Mazuecos AL, Mazzaschi F, Mazzilli M, Mdhluli JE, Melikyan Y, Menchaca-Rocha A, Mendez JEM, Meninno E, Menon AS, Meres M, Mhlanga S, Miake Y, Micheletti L, Mihaylov DL, Mikhaylov K, Mishra AN, Miśkowiec D, Modak A, Mohanty B, Mohisin Khan M, Molander MA, Monira S, Mordasini C, Moreira De Godoy DA, Morozov I, Morsch A, Mrnjavac T, Muccifora V, Muhuri S, Mulligan JD, Mulliri A, Munhoz MG, Munzer RH, Murakami H, Murray S, Musa L, Musinsky J, Myrcha JW, Naik B, Nambrath AI, Nandi BK, Nania R, Nappi E, Nassirpour AF, Nath A, Nattrass C, Naydenov MN, Neagu A, Negru A, Nekrasova E, Nellen L, Nepeivoda R, Nese S, Neskovic G, Nicassio N, Nielsen BS, Nielsen EG, Nikolaev S, Nikulin S, Nikulin V, Noferini F, Noh S, Nomokonov P, Norman J, Novitzky N, Nowakowski P, Nyanin A, Nystrand J, Ogino M, Oh S, Ohlson A, Okorokov VA, Oleniacz J, Oliveira Da Silva AC, Onnerstad A, Oppedisano C, Ortiz Velasquez A, Otwinowski J, Oya M, Oyama K, Pachmayer Y, Padhan S, Pagano D, Paić G, Paisano-Guzmán S, Palasciano A, Panebianco S, Park H, Park H, Park J, Parkkila JE, Patley Y, Patra RN, Paul B, Pei H, Peitzmann T, Peng X, Pennisi M, Perciballi S, Peresunko D, Perez GM, Pestov Y, Petrov V, Petrovici M, Pezzi RP, Piano S, Pikna M, Pillot P, Pinazza O, Pinsky L, Pinto C, Pisano S, Płoskoń M, Planinic M, Pliquett F, Poghosyan MG, Polichtchouk B, Politano S, Poljak N, Pop A, Porteboeuf-Houssais S, Pozdniakov V, Pozos IY, Pradhan KK, Prasad SK, Prasad S, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puccio M, Pucillo S, Pugelova Z, Qiu S, Quaglia L, Ragoni S, Rai A, Rakotozafindrabe A, Ramello L, Rami F, Rancien TA, Rasa M, Räsänen SS, Rath R, Rauch MP, Ravasenga I, Read KF, Reckziegel C, Redelbach AR, Redlich K, Reetz CA, Regules-Medel HD, Rehman A, Reidt F, Reme-Ness HA, Rescakova Z, Reygers K, Riabov A, Riabov V, Ricci R, Richter M, Riedel AA, Riegler W, Riffero AG, Ristea C, Rodriguez MV, Rodríguez Cahuantzi M, Rodríguez Ramírez SA, Røed K, Rogalev R, Rogochaya E, Rogoschinski TS, Rohr D, Röhrich D, Rojas PF, Rojas Torres S, Rokita PS, Romanenko G, Ronchetti F, Rosano A, Rosas ED, Roslon K, Rossi A, Roy A, Roy S, Rubini N, Ruggiano D, Rui R, Russek PG, Russo R, Rustamov A, Ryabinkin E, Ryabov Y, Rybicki A, Rytkonen H, Ryu J, Rzesa W, Saarimaki OAM, Sadhu S, Sadovsky S, Saetre J, Šafařík K, Saha P, Saha SK, Saha S, Sahoo B, Sahoo B, Sahoo R, Sahoo S, Sahu D, Sahu PK, Saini J, Sajdakova K, Sakai S, Salvan MP, Sambyal S, Samitz D, Sanna I, Saramela TB, Sarma P, Sarritzu V, Sarti VM, Sas MHP, Sawan S, Schambach J, Scheid HS, Schiaua C, Schicker R, Schlepper F, Schmah A, Schmidt C, Schmidt HR, Schmidt MO, Schmidt M, Schmidt NV, Schmier AR, Schotter R, Schröter A, Schukraft J, Schweda K, Scioli G, Scomparin E, Seger JE, Sekiguchi Y, Sekihata D, Selina M, Selyuzhenkov I, Senyukov S, Seo JJ, Serebryakov D, Šerkšnytė L, Sevcenco A, Shaba TJ, Shabetai A, Shahoyan R, Shangaraev A, Sharma A, Sharma B, Sharma D, Sharma H, Sharma M, Sharma S, Sharma S, Sharma U, Shatat A, Sheibani O, Shigaki K, Shimomura M, Shin J, Shirinkin S, Shou Q, Sibiriak Y, Siddhanta S, Siemiarczuk T, Silva TF, Silvermyr D, Simantathammakul T, Simeonov R, Singh B, Singh B, Singh K, Singh R, Singh R, Singh R, Singh S, Singh VK, Singhal V, Sinha T, Sitar B, Sitta M, Skaali TB, Skorodumovs G, Slupecki M, Smirnov N, Snellings RJM, Solheim EH, Song J, Sonnabend C, Soramel F, Soto-Hernandez AB, Spijkers R, Sputowska I, Staa J, Stachel J, Stan I, Steffanic PJ, Stiefelmaier SF, Stocco D, Storehaug I, Stratmann P, Strazzi S, Sturniolo A, Stylianidis CP, Suaide AAP, Suire C, Sukhanov M, Suljic M, Sultanov R, Sumberia V, Sumowidagdo S, Swain S, Szarka I, Szymkowski M, Taghavi SF, Taillepied G, Takahashi J, Tambave GJ, Tang S, Tang Z, Tapia Takaki JD, Tapus N, Tarasovicova LA, Tarzila MG, Tassielli GF, Tauro A, Tavira García A, Tejeda Muñoz G, Telesca A, Terlizzi L, Terrevoli C, Thakur S, Thomas D, Tikhonov A, Tiltmann N, Timmins AR, Tkacik M, Tkacik T, Toia A, Tokumoto R, Tomohiro K, Topilskaya N, Toppi M, Tork T, Torres VV, Torres Ramos AG, Trifiró A, Triolo AS, Tripathy S, Tripathy T, Trogolo S, Trubnikov V, Trzaska WH, Trzcinski TP, Tumkin A, Turrisi R, Tveter TS, Ullaland K, Ulukutlu B, Uras A, Usai GL, Vala M, Valle N, van Doremalen LVR, van Leeuwen M, van Veen CA, van Weelden RJG, Vande Vyvre P, Varga D, Varga Z, Vargas Torres P, Vasileiou M, Vasiliev A, Vázquez Doce O, Vazquez Rueda O, Vechernin V, Vercellin E, Vergara Limón S, Verma R, Vermunt L, Vértesi R, Verweij M, Vickovic L, Vilakazi Z, Villalobos Baillie O, Villani A, Vinogradov A, Virgili T, Virta MMO, Vislavicius V, Vodopyanov A, Volkel B, Völkl MA, Voloshin K, Voloshin SA, Volpe G, von Haller B, Vorobyev I, Vozniuk N, Vrláková J, Wan J, Wang C, Wang D, Wang Y, Wang Y, Wegrzynek A, Weiglhofer FT, Wenzel SC, Wessels JP, Wiechula J, Wikne J, Wilk G, Wilkinson J, Willems GA, Windelband B, Winn M, Wright JR, Wu W, Wu Y, Xu R, Yadav A, Yadav AK, Yalcin S, Yamaguchi Y, Yang S, Yano S, Yin Z, Yoo IK, Yoon JH, Yu H, Yuan S, Yuncu A, Zaccolo V, Zampolli C, Zanone F, Zardoshti N, Zarochentsev A, Závada P, Zaviyalov N, Zhalov M, Zhang B, Zhang C, Zhang L, Zhang S, Zhang X, Zhang Y, Zhang Z, Zhao M, Zherebchevskii V, Zhi Y, Zhou D, Zhou Y, Zhu J, Zhu Y, Zugravel SC, Zurlo N. Observation of Medium-Induced Yield Enhancement and Acoplanarity Broadening of Low-p_{T} Jets from Measurements in pp and Central Pb-Pb Collisions at sqrt[s_{NN}]=5.02 TeV. PHYSICAL REVIEW LETTERS 2024; 133:022301. [PMID: 39073970 DOI: 10.1103/physrevlett.133.022301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 05/06/2024] [Accepted: 05/13/2024] [Indexed: 07/31/2024]
Abstract
The ALICE Collaboration reports the measurement of semi-inclusive distributions of charged-particle jets recoiling from a high transverse momentum (high p_{T}) hadron trigger in proton-proton and central Pb-Pb collisions at sqrt[s_{NN}]=5.02 TeV. A data-driven statistical method is used to mitigate the large uncorrelated background in central Pb-Pb collisions. Recoil jet distributions are reported for jet resolution parameter R=0.2, 0.4, and 0.5 in the range 7
Collapse
|
32
|
Zhang X, Wen X, Peng R, Pan Q, Weng D, Ma Y, Zhang Y, Yang J, Men L, Wang H, Liang E, Wang C, Yang D, Zhang L, Zhai Y. A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors. ESMO Open 2024; 9:103636. [PMID: 39002360 DOI: 10.1016/j.esmoop.2024.103636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Revised: 06/04/2024] [Accepted: 06/05/2024] [Indexed: 07/15/2024] Open
Abstract
BACKGROUND The mouse double minute 2 homolog (MDM2) oncogene exerts oncogenic activities in many cancers and represents a potential therapeutic target. This trial evaluated the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of alrizomadlin (APG-115), a novel MDM2/p53 inhibitor, in patients with advanced solid tumors. PATIENTS AND METHODS Patients with histologically confirmed advanced solid tumors who had progressed to standard treatment or lacked effective therapies were recruited. Alrizomadlin was administered once daily every other day for 21 days of a 28-day cycle until disease progression or intolerable toxicity. RESULTS A total of 21 patients were enrolled and treated with alrizomadlin; 57.1% were male and the median age was 47 (25-60) years. The maximum tolerated dose of alrizomadlin was 150 mg and the recommended phase II dose was 100 mg. One patient in the 200-mg cohort experienced dose-limiting toxicity of thrombocytopenia and febrile neutropenia. The most common grade 3/4 treatment-related adverse events were thrombocytopenia (33.3%), lymphocytopenia (33.3%), neutropenia (23.8%), and anemia (23.8%). Alrizomadlin demonstrated approximately linear pharmacokinetics (dose range 100-200 mg) and was associated with increased plasma macrophage inhibitory cytokine-1, indicative of p53 pathway activation. Of the 20 assessable patients, 2 [10%, 95% confidence interval (CI) 1.2% to 31.7%] patients achieved partial response and 10 (50%, 95% CI 27.2% to 72.8%) showed stable disease. The median progression-free survival was 6.1 (95% CI 1.7-10.4) months, which was significantly longer in patients with wild-type versus mutant TP53 (7.9 versus 2.2 months, respectively; P < 0.001). Among patients with MDM2 amplification and wild-type TP53, the overall response rate was 25% (2/8) and the disease control rate was 100% (8/8). CONCLUSIONS Alrizomadlin had an acceptable safety profile and demonstrated promising antitumor activity in MDM2-amplified and TP53 wild-type tumors. This study supports further exploration of alrizomadlin with recommended doses of 100 mg q.o.d. in 21 days on and 7 days off regimen.
Collapse
|
33
|
Peng X, Zhang X, Lu HX, Shen LL, Gao N, Zan LK. [Detection of PIK3CA gene mutation and its related prognosis in colorectal cancer based on next-generation sequencing]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2024; 53:716-721. [PMID: 38955704 DOI: 10.3760/cma.j.cn112151-20231113-00355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/04/2024]
Abstract
Objectives: To investigate the mutation of PIK3CA in colorectal cancer and to analyze their clinicopathological features, and evaluate their role in clinical treatment and prognostication. Methods: A total of 128 paraffin-embbeded tissue samples of colorectal cancer from Shanxi Cancer Hospital from 2018 to 2021 were collected. DNA was extracted from the samples, and next-generation sequencing (NGS) was used to detect PIK3CA mutation. The relationship between PIK3CA mutation, their clinicopathological features, and prognosis were analyzed. Results: Among the 128 colorectal cancer samples, there were 75 males and 53 females; with aged range 32-86 years, median 61.5 years, 27 (21.09%) had PIK3CA mutations. Colorectal cancer with PIK3CA mutation was more likely to occur in male patients (P=0.007), which was related to tumor site (P=0.032), tumor size (P=0.029) and TP53 wild-type (P=0.001). The common site mutations of PIK3CA mostly occurred in tumors with tumor mutation burden≥10 Muts/Mb (P=0.031).PIK3CA mutation had no significant effect on the survival prognosis of patients, but the efficacy of anti-angiogenic therapy was poor in these patients. Conclusions: PIK3CA mutation is a common mutation in colorectal cancer and plays an important role in the occurrence and development of colorectal cancer. PIK3CA mutation may lead to resistance to anti-angiogenic drugs in colorectal cancer, but its impact on survival and prognosis to patients needs further study.
Collapse
|
34
|
Zheng YX, Zhang X, Su J. [Advance on TERT gene in melanoma]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2024; 53:762-766. [PMID: 38955717 DOI: 10.3760/cma.j.cn112151-20231106-00337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/04/2024]
|
35
|
Qu R, Wan S, Zhang X, Wang X, Xue L, Wang Q, Cheng GJ, Dai L, Lian Z. Mechanical-Force-Induced Non-spontaneous Dehalogenative Deuteration of Aromatic Iodides Enabled by Using Piezoelectric Materials as a Redox Catalyst. Angew Chem Int Ed Engl 2024; 63:e202400645. [PMID: 38687047 DOI: 10.1002/anie.202400645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2024] [Revised: 04/25/2024] [Accepted: 04/30/2024] [Indexed: 05/02/2024]
Abstract
The development of green and efficient deuteration methods is of great significance for various fields such as organic synthesis, analytical chemistry, and medicinal chemistry. Herein, we have developed a dehalogenative deuteration strategy using piezoelectric materials as catalysts in a solid-phase system under ball-milling conditions. This non-spontaneous reaction is induced by mechanical force. D2O can serve as both a deuterium source and an electron donor in the transformation, eliminating the need for additional stoichiometric exogenous reductants. A series of (hetero)aryl iodides can be transformed into deuterated products with high deuterium incorporation. This method not only effectively overcomes existing synthetic challenges but can also be used for deuterium labelling of drug molecules and derivatives. Bioactivity experiments with deuterated drug molecule suggest that the D-ipriflavone enhances the inhibitory effects on osteoclast differentiation of BMDMs in vitro.
Collapse
|
36
|
Aad G, Abbott B, Abeling K, Abicht N, Abidi S, Aboulhorma A, Abramowicz H, Abreu H, Abulaiti Y, Abusleme Hoffman A, Acharya B, Adam Bourdarios C, Adamczyk L, Adamek L, Addepalli S, Addison M, Adelman J, Adiguzel A, Adye T, Affolder A, Afik Y, Agaras M, Agarwala J, Aggarwal A, Agheorghiesei C, Ahmad A, Ahmadov F, Ahmed W, Ahuja S, Ai X, Aielli G, Aikot A, Ait Tamlihat M, Aitbenchikh B, Aizenberg I, Akbiyik M, Åkesson T, Akimov A, Akiyama D, Akolkar N, Al Khoury K, Alberghi G, Albert J, Albicocco P, Albouy G, Alderweireldt S, Aleksa M, Aleksandrov I, Alexa C, Alexopoulos T, Alfonsi F, Algren M, Alhroob M, Ali B, Ali H, Ali S, Alibocus S, Aliev M, Alimonti G, Alkakhi W, Allaire C, Allbrooke B, Allen J, Allendes Flores C, Allport P, Aloisio A, Alonso F, Alpigiani C, Alvarez Estevez M, Alvarez Fernandez A, Alves Cardoso M, Alviggi M, Aly M, Amaral Coutinho Y, Ambler A, Amelung C, Amerl M, Ames C, Amidei D, Amor Dos Santos S, Amos K, Ananiev V, Anastopoulos C, Andeen T, Anders J, Andrean S, Andreazza A, Angelidakis S, Angerami A, Anisenkov A, Annovi A, Antel C, Anthony M, Antipov E, Antonelli M, Anulli F, Aoki M, Aoki T, Aparisi Pozo J, Aparo M, Bella LA, Appelt C, Apyan A, Aranzabal N, Arcangeletti C, Arce A, Arena E, Arguin JF, Argyropoulos S, Arling JH, Arnaez O, Arnold H, Artoni G, Asada H, Asai K, Asai S, Asbah N, Assahsah J, Assamagan K, Astalos R, Atashi S, Atkin R, Atkinson M, Atmani H, Atmasiddha P, Augsten K, Auricchio S, Auriol A, Austrup V, Avolio G, Axiotis K, Azuelos G, Babal D, Bachacou H, Bachas K, Bachiu A, Backman F, Badea A, Bagnaia P, Bahmani M, Bailey A, Bailey V, Baines J, Baines L, Bakalis C, Baker O, Bakos E, Bakshi Gupta D, Balakrishnan V, Balasubramanian R, Baldin E, Balek P, Ballabene E, Balli F, Baltes L, Balunas W, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Bansal S, Barak L, Barakat M, Barberio E, Barberis D, Barbero M, Barends K, Barillari T, Barisits MS, Barklow T, Baron P, Baron Moreno D, Baroncelli A, Barone G, Barr A, Barr J, Barranco Navarro L, Barreiro F, da Costa JBG, Barron U, Barros Teixeira M, Barsov S, Bartels F, Bartoldus R, Barton A, Bartos P, Basan A, Baselga M, Bassalat A, Basso M, Basson C, Bates R, Batlamous S, Batley J, Batool B, Battaglia M, Battulga D, Bauce M, Bauer M, Bauer P, Bazzano Hurrell L, Beacham J, Beau T, Beauchemin P, Becherer F, Bechtle P, Beck H, Becker K, Beddall A, Bednyakov V, Bee C, Beemster L, Beermann T, Begalli M, Begel M, Behera A, Behr J, Beirer J, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belyaev N, Benchekroun D, Bendebba F, Benhammou Y, Benoit M, Bensinger J, Bentvelsen S, Beresford L, Beretta M, Bergeaas Kuutmann E, Berger N, Bergmann B, Beringer J, Bernardi G, Bernius C, Bernlochner F, Bernon F, Berry T, Berta P, Berthold A, Bertram I, Bethke S, Betti A, Bevan A, Bhamjee M, Bhatta S, Bhattacharya D, Bhattarai P, Bhopatkar V, Bi R, Bianchi R, Bianco G, Biebel O, Bielski R, Biglietti M, Billoud T, Bindi M, Bingul A, Bini C, Biondini A, Birch-sykes C, Bird G, Birman M, Biros M, Bisanz T, Bisceglie E, Biswas D, Bitadze A, Bjørke K, Bloch I, Blocker C, Blue A, Blumenschein U, Blumenthal J, Bobbink G, Bobrovnikov V, Boehler M, Boehm B, Bogavac D, Bogdanchikov A, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Boonekamp M, Booth C, Borbély A, Bordulev I, Borecka-Bielska H, Borgna L, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola J, Bouaouda K, Bouchhar N, Boudreau J, Bouhova-Thacker E, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko I, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau J, Brener R, Brenner L, Brenner R, Bressler S, Britton D, Britzger D, Brock I, Brooijmans G, Brooks W, Brost E, Brown L, Bruce L, Bruckler T, de Renstrom PB, Brüers B, Bruni A, Bruni G, Bruschi M, Bruscino N, Buanes T, Buat Q, Buchin D, Buckley A, Bugge M, Bulekov O, Bullard B, Burdin S, Burgard C, Burger A, Burghgrave B, Burlayenko O, Burr J, Burton C, Burzynski J, Busch E, Büscher V, Bussey P, Butler J, Buttar C, Butterworth J, Buttinger W, Buxo Vazquez C, Buzykaev A, Cabrera Urbán S, Cadamuro L, Caforio D, Cai H, Cai Y, Cairo V, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba L, Calvet D, Calvet S, Calvet T, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo M, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canesse A, Cantero J, Cao Y, Capocasa F, Capua M, Carbone A, Cardarelli R, Cardenas J, Cardillo F, Carli T, Carlino G, Carlotto J, Carlson B, Carlson E, Carminati L, Carnelli A, Carnesale M, Caron S, Carquin E, Carrá S, Carratta G, Carrio Argos F, Carter J, Carter T, Casado M, Caspar M, Castiglia E, Castillo F, Castillo Garcia L, Castillo Gimenez V, Castro N, Catinaccio A, Catmore J, Cavaliere V, Cavalli N, Cavasinni V, Cekmecelioglu Y, Celebi E, Celli F, Centonze M, Cepaitis V, Cerny K, Cerqueira A, Cerri A, Cerrito L, Cerutti F, Cervato B, Cervelli A, Cesarini G, Cetin S, Chadi Z, Chakraborty D, Chan J, Chan W, Chapman J, Chapon E, Chargeishvili B, Charlton D, Charman T, Chatterjee M, Chauhan C, Chekanov S, Chekulaev S, Chelkov G, Chen A, Chen B, Chen B, Chen H, Chen H, Chen J, Chen J, Chen M, Chen S, Chen S, Chen X, Chen X, Chen Y, Cheng C, Cheng H, Cheong S, Cheplakov A, Cheremushkina E, Cherepanova E, El Moursli RC, Cheu E, Cheung K, Chevalier L, Chiarella V, Chiarelli G, Chiedde N, Chiodini G, Chisholm A, Chitan A, Chitishvili M, Chizhov M, Choi K, Chomont A, Chou Y, Chow E, Chowdhury T, Chu K, Chu M, Chu X, Chudoba J, Chwastowski J, Cieri D, Ciesla K, Cindro V, Ciocio A, Cirotto F, Citron Z, Citterio M, Ciubotaru D, Ciungu B, Clark A, Clark P, Clavijo Columbie J, Clawson S, Clement C, Clercx J, Clissa L, Coadou Y, Cobal M, Coccaro A, Coelho Barrue R, De Sa RCL, Coelli S, Cohen H, Coimbra A, Cole B, Collot J, Conde Muiño P, Connell M, Connell S, Connelly I, Conroy E, Conventi F, Cooke H, Cooper-Sarkar A, Cordeiro Oudot Choi A, Cormier F, Corpe L, Corradi M, Corriveau F, Cortes-Gonzalez A, Costa M, Costanza F, Costanzo D, Cote B, Cowan G, Cranmer K, Cremonini D, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosby J, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cui Z, Cunningham W, Curcio F, Czodrowski P, Czurylo M, De Sousa MDCS, Pinto JDF, Da Via C, Dabrowski W, Dado T, Dahbi S, Dai T, Santo DD, Dallapiccola C, Dam M, D’amen G, D’Amico V, Damp J, Dandoy J, Daneri M, Danninger M, Dao V, Darbo G, Darmora S, Das S, D’Auria S, David C, Davidek T, Davis-Purcell B, Dawson I, Day-hall H, De K, De Asmundis R, De Biase N, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Salvo A, De Sanctis U, De Santo A, De Regie JDV, Dedovich D, Degens J, Deiana A, Del Corso F, Del Peso J, Del Rio F, Deliot F, Delitzsch C, Della Pietra M, Della Volpe D, Dell’Acqua A, Dell’Asta L, Delmastro M, Delsart P, Demers S, Demichev M, Denisov S, D’Eramo L, Derendarz D, Derue F, Dervan P, Desch K, Deutsch C, Di Bello F, Di Ciaccio A, Di Ciaccio L, Di Domenico A, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Diaconu C, Diamantopoulou M, Dias F, Do Vale TD, Diaz M, Diaz Capriles F, Didenko M, Diehl E, Diehl L, Díez Cornell S, Diez Pardos C, Dimitriadi C, Dimitrievska A, Dingfelder J, Dinu IM, Dittmeier S, Dittus F, Djama F, Djobava T, Djuvsland J, Doglioni C, Dohnalova A, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D’Onofrio A, D’Onofrio M, Dopke J, Doria A, Dos Santos Fernandes N, Dougan P, Dova M, Doyle A, Draguet M, Dreyer E, Drivas-koulouris I, Drobac A, Drozdova M, Du D, du Pree T, Dubinin F, Dubovsky M, Duchovni E, Duckeck G, Ducu O, Duda D, Dudarev A, Duden E, D’uffizi M, Duflot L, Dührssen M, Dülsen C, Dumitriu A, Dunford M, Dungs S, Dunne K, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Dwyer B, Dyckes G, Dyndal M, Dysch S, Dziedzic B, Earnshaw Z, Eberwein G, Eckerova B, Eggebrecht S, De Souza EEP, Ehrke L, Eigen G, Einsweiler K, Ekelof T, Ekman P, El Farkh S, El Ghazali Y, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Elliot A, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Enari Y, Ene I, Epari S, Erdmann J, Erland P, Errenst M, Escalier M, Escobar C, Etzion E, Evans G, Evans H, Evans L, Evans M, Ezhilov A, Ezzarqtouni S, Fabbri F, Fabbri L, Facini G, Fadeyev V, Fakhrutdinov R, Falciano S, Falda Ulhoa Coelho L, Falke P, Faltova J, Fan C, Fan Y, Fang Y, Fanti M, Faraj M, Farazpay Z, Farbin A, Farilla A, Farooque T, Farrington S, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett W, Fayard L, Federic P, Federicova P, Fedin O, Fedotov G, Feickert M, Feligioni L, Fellers D, Feng C, Feng M, Feng Z, Fenton M, Fenyuk A, Ferencz L, Ferguson R, Fernandez Luengo S, Fernoux M, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filmer E, Filthaut F, Fiolhais M, Fiorini L, Fisher W, Fitschen T, Fitzhugh P, Fleck I, Fleischmann P, Flick T, Flores M, Flores Castillo L, De Acedo LFS, Follega F, Fomin N, Foo J, Forland B, Formica A, Forti A, Fortin E, Fortman A, Foti M, Fountas L, Fournier D, Fox H, Francavilla P, Francescato S, Franchellucci S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Freegard A, Freund W, Frid Y, Friend J, Fritzsche N, Froch A, Froidevaux D, Frost J, Fu Y, Fujimoto M, Fullana Torregrosa E, Fung K, Furtado De Simas Filho E, Furukawa M, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon L, Gallas E, Gallop B, Gan K, Ganguly S, Gao J, Gao Y, Garay Walls F, Garcia B, García C, Garcia Alonso A, Garcia Caffaro A, García Navarro J, Garcia-Sciveres M, Gardner G, Gardner R, Garelli N, Garg D, Garg R, Gargan J, Garner C, Gasiorowski S, Gaspar P, Gaudio G, Gautam V, Gauzzi P, Gavrilenko I, Gavrilyuk A, Gay C, Gaycken G, Gazis E, Geanta A, Gee C, Gemme C, Genest M, Gentile S, George S, George W, Geralis T, Gessinger-Befurt P, Geyik M, Ghani M, Ghneimat M, Ghorbanian K, Ghosal A, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giani T, Giannetti P, Giannini A, Gibson S, Gignac M, Gil D, Gilbert A, Gilbert B, Gillberg D, Gilles G, Gillwald N, Ginabat L, Gingrich D, Giordani M, Giraud P, Giugliarelli G, Giugni D, Giuli F, Gkialas I, Gladilin L, Glasman C, Gledhill G, Glemža G, Glisic M, Gnesi I, Go Y, Goblirsch-Kolb M, Gocke B, Godin D, Gokturk B, Goldfarb S, Golling T, Gololo M, Golubkov D, Gombas J, Gomes A, Da Silva GG, Gomez Delegido A, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski J, González Andana R, de la Hoz SG, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Rodrigues M, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez G, Goossens L, Gorini B, Gorini E, Gorišek A, Gosart T, Goshaw A, Gostkin M, Goswami S, Gottardo C, Gotz S, Gouighri M, Goumarre V, Goussiou A, Govender N, Grabowska-Bold I, Graham K, Gramstad E, Grancagnolo S, Grandi M, Grant C, Gravila P, Gravili F, Gray H, Greco M, Grefe C, Gregor I, Grenier P, Grieco C, Grillo A, Grimm K, Grinstein S, Grivaz JF, Gross E, Grosse-Knetter J, Grud C, Grundy J, Guan L, Guan W, Gubbels C, Guerrero Rojas J, Guerrieri G, Guescini F, Gugel R, Guhit J, Guida A, Guillemin T, Guilloton E, Guindon S, Guo F, Guo J, Guo L, Guo Y, Gupta R, Gurbuz S, Gurdasani S, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta L, Gutschow C, Gwenlan C, Gwilliam C, Haaland E, Haas A, Habedank M, Haber C, Hadavand H, Hadef A, Hadzic S, Hahn J, Haines E, Haleem M, Haley J, Hall J, Hallewell G, Halser L, Hamano K, Hamer M, Hamity G, Hampshire E, Han J, Han K, Han L, Han L, Han S, Han Y, Hanagaki K, Hance M, Hangal D, Hanif H, Hank M, Hankache R, Hansen J, Hansen J, Hansen P, Hara K, Harada D, Harenberg T, Harkusha S, Harris M, Harris Y, Harrison J, Harrison N, Harrison P, Hartman N, Hartmann N, Hasegawa Y, Hasib A, Haug S, Hauser R, Hawkes C, Hawkings R, Hayashi Y, Hayashida S, Hayden D, Hayes C, Hayes R, Hays C, Hays J, Hayward H, He F, He M, He Y, He Y, Heatley N, Hedberg V, Heggelund A, Hehir N, Heidegger C, Heidegger K, Heidorn W, Heilman J, Heim S, Heim T, Heinlein J, Heinrich J, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling C, Hellman S, Henderson R, Henkelmann L, Henriques Correia A, Herde H, Hernández Jiménez Y, Herrmann L, Herrmann T, Herten G, Hertenberger R, Hervas L, Hesping M, Hessey N, Hibi H, Hillier S, Hinds J, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hitchings T, Hiti B, Hobbs J, Hobincu R, Hod N, Hodgkinson M, Hodkinson B, Hoecker A, Hofer J, Holm T, Holzbock M, Hommels L, Honan B, Hong J, Hong T, Hooberman B, Hopkins W, Horii Y, Hou S, Howard A, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn’ova T, Hsu P, Hsu SC, Hu Q, Hu Y, Huang S, Huang X, Huang Y, Huang Y, Huang Z, Hubacek Z, Huebner M, Huegging F, Huffman T, Hugli C, Huhtinen M, Huiberts S, Hulsken R, Huseynov N, Huston J, Huth J, Hyneman R, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Lezki MI, Carlson TI, Introzzi G, Iodice M, Ippolito V, Irwin R, Ishino M, Islam W, Issever C, Istin S, Ito H, Ponce JI, Iuppa R, Ivina A, Izen J, Izzo V, Jacka P, Jackson P, Jacobs R, Jaeger B, Jagfeld C, Jain P, Jäkel G, Jakobs K, Jakoubek T, Jamieson J, Janas K, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jessiman C, Jézéquel S, Jia C, Jia J, Jia X, Jia X, Jia Z, Jiang Y, Jiggins S, Pena JJ, Jin S, Jinaru A, Jinnouchi O, Johansson P, Johns K, Johnson J, Jones D, Jones E, Jones P, Jones R, Jones T, Joshi R, Jovicevic J, Ju X, Junggeburth J, Junkermann T, Rozas AJ, Juzek M, Kabana S, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kakati N, Kalaitzidou I, Kalderon C, Kamenshchikov A, Kang N, Kar D, Karava K, Kareem M, Karentzos E, Karkanias I, Karkout O, Karpov S, Karpova Z, Kartvelishvili V, Karyukhin A, Kasimi E, Katzy J, Kaur S, Kawade K, Kawale M, Kawamoto T, Kay E, Kaya F, Kazakos S, Kazanin V, Ke Y, Keaveney J, Keeler R, Kehris G, Keller J, Kelly A, Kempster J, Kennedy K, Kennedy P, Kepka O, Kerridge B, Kersten S, Kerševan B, Keshri S, Keszeghova L, Haghighat SK, Khandoga M, Khanov A, Kharlamov A, Kharlamova T, Khoda E, Khoo T, Khoriauli G, Khubua J, Khwaira Y, Kilgallon A, Kim D, Kim Y, Kimura N, Kirchhoff A, Kirfel C, Kirfel F, Kirk J, Kiryunin A, Kitsaki C, Kivernyk O, Klassen M, Klein C, Klein L, Klein M, Klein M, Klein S, Klein U, Klimek P, Klimentov A, Klioutchnikova T, Kluit P, Kluth S, Kneringer E, Knight T, Knue A, Kobayashi R, Kobylianskii D, Koch S, Kocian M, Kodyš P, Koeck D, Koenig P, Koffas T, Kolb M, Koletsou I, Komarek T, Köneke K, Kong A, Kono T, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korn S, Korolkov I, Korotkova N, Kortman B, Kortner O, Kortner S, Kostecka W, Kostyukhin V, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kovanda O, Kowalewski R, Kozanecki W, Kozhin A, Kramarenko V, Kramberger G, Kramer P, Krasny M, Krasznahorkay A, Kraus J, Kremer J, Kresse T, Kretzschmar J, Kreul K, Krieger P, Krishnamurthy S, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman K, Kruchonak U, Krüger H, Krumnack N, Kruse M, Krzysiak J, Kuchinskaia O, Kuday S, Kuehn S, Kuesters R, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kumar M, Kumari N, Kupco A, Kupfer T, Kupich A, Kuprash O, Kurashige H, Kurchaninov L, Kurdysh O, Kurochkin Y, Kurova A, Kuze M, Kvam A, Kvita J, Kwan T, Kyriacou N, Laatu L, Lacasta C, Lacava F, Lacker H, Lacour D, Lad N, Ladygin E, Laforge B, Lagouri T, Lahbabi F, Lai S, Lakomiec I, Lalloue N, Lambert J, Lammers S, Lampl W, Lampoudis C, Lancaster A, Lançon E, Landgraf U, Landon M, Lang V, Langenberg R, Langrekken O, Lankford A, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte J, Lari T, Manghi FL, Lassnig M, Latonova V, Laudrain A, Laurier A, Lawlor S, Lawrence Z, Lazzaroni M, Le B, Le Boulicaut E, Leban B, Lebedev A, LeBlanc M, Ledroit-Guillon F, Lee A, Lee S, Lee S, Lee T, Leeuw L, Lefebvre H, Lefebvre M, Leggett C, Miotto GL, Leigh M, Leight W, Leinonen W, Leisos A, Leite M, Leitgeb C, Leitner R, Leney K, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester C, Levchenko M, Levêque J, Levin D, Levinson L, Lewicki M, Lewis D, Li A, Li B, Li C, Li CQ, Li H, Li H, Li H, Li H, Li H, Li K, Li L, Li M, Li Q, Li S, Li S, Li T, Li X, Li Z, Li Z, Li Z, Li Z, Liang S, Liang Z, Liberatore M, Liberti B, Lie K, Marin JL, Lien H, Lin K, Lindley R, Lindon J, Lipeles E, Lipniacka A, Lister A, Little J, Liu B, Liu B, Liu D, Liu J, Liu J, Liu K, Liu M, Liu M, Liu P, Liu Q, Liu X, Liu Y, Liu Y, Liu Y, Merino JL, Lloyd S, Lobodzinska E, Loch P, Loffredo S, Lohse T, Lohwasser K, Loiacono E, Lokajicek M, Lomas J, Long J, Longarini I, Longo L, Longo R, Paz IL, Solis AL, Lorenz J, Martinez NL, Lory A, Centeno GL, Loseva O, Lou X, Lou X, Lounis A, Love J, Love P, Lu G, Lu M, Lu S, Lu Y, Lubatti H, Luci C, Alves FL, Lucotte A, Luehring F, Luise I, Lukianchuk O, Lundberg O, Lund-Jensen B, Luongo N, Lutz M, Lynn D, Lyons H, Lysak R, Lytken E, Lyubushkin V, Lyubushkina T, Lyukova M, Ma H, Ma K, Ma L, Ma Y, Donell DM, Maccarrone G, MacDonald J, Madar R, Mader W, Madula T, Maeda J, Maeno T, Maerker M, Maguire H, Maiboroda V, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Maksimovic V, Malaescu B, Malecki P, Maleev V, Malek F, Mali M, Malito D, Mallik U, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Manco G, Mandalia J, Mandić I, de Andrade Filho LM, Maniatis I, Ramos JM, Mankad D, Mann A, Mansoulie B, Manzoni S, Marantis A, Marchiori G, Marcisovsky M, Marcon C, Marinescu M, Marjanovic M, Marshall E, Marshall Z, Marti-Garcia S, Martin T, Martin V, Martin dit Latour B, Martinelli L, Martinez M, Agullo PM, Outschoorn VM, Suarez PM, Martin-Haugh S, Martoiu V, Martyniuk A, Marzin A, Mascione D, Masetti L, Mashimo T, Masik J, Maslennikov A, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Mathisen T, Matousek J, Matsuzawa N, Maurer J, Maček B, Maximov D, Mazini R, Maznas I, Mazza M, Mazza S, Mazzeo E, Ginn CM, Gowan JM, Kee SM, McDonald E, McDougall A, Mcfayden J, McGovern R, Mchedlidze G, Mckenzie R, Mclachlan T, Mclaughlin D, McLean K, McMahon S, McNamara P, Mcpartland C, McPherson R, Mehlhase S, Mehta A, Melini D, Garcia BM, Melo A, Meloni F, Da Costa AMJ, Meng H, Meng L, Menke S, Mentink M, Meoni E, Merlassino C, Merola L, Meroni C, Merz G, Meshkov O, Metcalfe J, Mete A, Meyer C, Meyer JP, Middleton R, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke C, Miller D, Miller L, Milov A, Milstead D, Min T, Minaenko A, Minashvili I, Mince L, Mincer A, Mindur B, Mineev M, Mino Y, Mir L, Lopez MM, Mironova M, Mishima A, Missio M, Mitra A, Mitsou V, Mitsumori Y, Miu O, Miyagawa P, Mkrtchyan T, Mlinarevic M, Mlinarevic T, Mlynarikova M, Mobius S, Moder P, Mogg P, Mohammed A, Mohapatra S, Mokgatitswane G, Moleri L, Mondal B, Mondal S, Monig G, Mönig K, Monnier E, Romero LM, Berlingen JM, Montella M, Montereali F, Monticelli F, Monzani S, Morange N, De Carvalho AM, Llácer MM, Martinez CM, Morettini P, Morgenstern S, Morii M, Morinaga M, Morley A, Morodei F, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse E, Mtintsilana O, Muanza S, Mueller J, Muenstermann D, Müller R, Mullier G, Mullin A, Mullin J, Mungo D, Perez DM, Sanchez FM, Murin M, Murray W, Murrone A, Muse J, Muškinja M, Mwewa C, Myagkov A, Myers A, Myers A, Myers G, Myska M, Nachman B, Nackenhorst O, Nag A, Nagai K, Nagano K, Nagle J, Nagy E, Nairz A, Nakahama Y, Nakamura K, Nakkalil K, Nanjo H, Narayan R, Narayanan E, Naryshkin I, Naseri M, Nasri S, Nass C, Navarro G, Navarro-Gonzalez J, Nayak R, Nayaz A, Nechaeva P, Nechansky F, Nedic L, Neep T, Negri A, Negrini M, Nellist C, Nelson C, Nelson K, Nemecek S, Nessi M, Neubauer M, Neuhaus F, Neundorf J, Newhouse R, Newman P, Ng C, Ng Y, Ngair B, Nguyen H, Nickerson R, Nicolaidou R, Nielsen J, Niemeyer M, Niermann J, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Ninca I, Nindhito H, Ninio G, Nisati A, Nishu N, Nisius R, Nitschke JE, Nkadimeng E, Rosende SN, Nobe T, Noel D, Nommensen T, Norfolk M, Norisam R, Norman B, Novak J, Novak T, Novotny L, Novotny R, Nozka L, Ntekas K, Nunes De Moura Junior N, Nurse E, Ocariz J, Ochi A, Ochoa I, Oerdek S, Offermann J, Ogrodnik A, Oh A, Ohm C, Oide H, Oishi R, Ojeda M, O’Keefe M, Okumura Y, Seabra LO, Pino SO, Damazio DO, Goncalves DO, Oliver J, Olszewski A, Öncel Ö, O’Neill A, Onofre A, Onyisi P, Oreglia M, Orellana G, Orestano D, Orlando N, Orr R, O’Shea V, Osojnak L, Ospanov R, Otero y Garzon G, Otono H, Ott P, Ottino G, Ouchrif M, Ouellette J, Ould-Saada F, Owen M, Owen R, Oyulmaz K, Ozcan V, Ozturk N, Ozturk S, Pacey H, Pages AP, Aranda CP, Padovano G, Griso SP, Palacino G, Palazzo A, Palestini S, Pan J, Pan T, Panchal D, Pandini C, Vazquez JP, Pandya H, Pang H, Pani P, Panizzo G, Paolozzi L, Papadatos C, Parajuli S, Paramonov A, Paraskevopoulos C, Hernandez DP, Park T, Parker M, Parodi F, Parrish E, Parrish V, Parsons J, Parzefall U, Dias BP, Dominguez LP, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Patel P, Patel U, Pater J, Pauly T, Pearkes J, Pedersen M, Pedro R, Peleganchuk S, Penc O, Pender E, Peng H, Penski K, Penzin M, Peralva B, Peixoto AP, Sanchez LP, Perepelitsa D, Codina EP, Perganti M, Perini L, Pernegger H, Perrin O, Peters K, Peters R, Petersen B, Petersen T, Petit E, Petousis V, Petridou C, Petrukhin A, Pettee M, Pettersson N, Petukhov A, Petukhova K, Pezoa R, Pezzotti L, Pezzullo G, Pham T, Pham T, Phillips P, Piacquadio G, Pianori E, Piazza F, Piegaia R, Pietreanu D, Pilkington A, Pinamonti M, Pinfold J, Pereira BP, Pinoargote AP, Pintucci L, Piper K, Pirttikoski A, Pizzi D, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Poddar G, Poettgen R, Poggioli L, Pokharel I, Polacek S, Polesello G, Poley A, Polifka R, Polini A, Pollard C, Pollock Z, Polychronakos V, Pacchi EP, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu G, Poreba A, Quintero DP, Pospisil S, Postill M, Postolache P, Potamianos K, Potepa P, Potrap I, Potter C, Potti H, Poulsen T, Poveda J, Astigarraga MP, Ibanez AP, Pretel J, Price D, Primavera M, Martin MP, Privara R, Procter T, Proffitt M, Proklova N, Prokofiev K, Proto G, Protopopescu S, Proudfoot J, Przybycien M, Przygoda W, Puddefoot J, Pudzha D, Pyatiizbyantseva D, Qian J, Qichen D, Qin Y, Qiu T, Quadt A, Queitsch-Maitland M, Quetant G, Quinn R, Bolanos GR, Rafanoharana D, Ragusa F, Rainbolt J, Raine J, Rajagopalan S, Ramakoti E, Ran K, Rapheeha N, Rasheed H, Raskina V, Rassloff D, Rave S, Ravina B, Ravinovich I, Raymond M, Read A, Readioff N, Rebuzzi D, Redlinger G, Reed A, Reeves K, Reidelsturz J, Reikher D, Rej A, Rembser C, Renardi A, Renda M, Rendel M, Renner F, Rennie A, Rescia A, Resconi S, Ressegotti M, Rettie S, Rivera JR, Reynolds E, Rezanova O, Reznicek P, Ribaric N, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Ridouani S, Rieck P, Riedler P, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn T, Rinnagel M, Ripellino G, Riu I, Rivadeneira P, Vergara JR, Rizatdinova F, Rizvi E, Roberts B, Roberts B, Robertson S, Robinson D, Gajardo CR, Manzano MR, Robson A, Rocchi A, Roda C, Bosca SR, Garcia YR, Rodriguez AR, Vera AR, Roe S, Roemer J, Roepe-Gier A, Roggel J, Røhne O, Rojas R, Roland C, Roloff J, Romaniouk A, Romano E, Romano M, Hernandez AR, Rompotis N, Roos L, Rosati S, Rosser B, Rossi E, Rossi E, Rossi L, Rossini L, Rosten R, Rotaru M, Rottler B, Rougier C, Rousseau D, Rousso D, Roy A, Roy-Garand S, Rozanov A, Rozen Y, Ruan X, Jimenez AR, Ruby A, Rivera VR, Ruggeri T, Ruggiero A, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich N, Russell H, Russo G, Rutherfoord J, Colmenares SR, Rybacki K, Rybar M, Rye E, Ryzhov A, Iglesias JS, Sabatini P, Sabetta L, Sadrozinski HW, Tehrani FS, Samani BS, Safdari M, Saha S, Sahinsoy M, Saimpert M, Saito M, Saito T, Salamani D, Salnikov A, Salt J, Salas AS, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Pineda AS, Sebastian VS, Sandaker H, Sander C, Sandesara J, Sandhoff M, Sandoval C, Sankey D, Sano T, Sansoni A, Santi L, Santoni C, Santos H, Santpur S, Santra A, Saoucha K, Saraiva J, Sardain J, Sasaki O, Sato K, Sauer C, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Galvan IS, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schäfer U, Schaffer A, Schaile D, Schamberger R, Scharf C, Schefer M, Schegelsky V, Scheirich D, Schenck F, Schernau M, Scheulen C, Schiavi C, Schioppa E, Schioppa M, Schlag B, Schleicher K, Schlenker S, Schmeing J, Schmidt M, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer P, Schopf E, Schott M, Schovancova J, Schramm S, Schroeder F, Schroer T, Schultz-Coulon HC, Schumacher M, Schumm B, Schune P, Schuy A, Schwartz H, Schwartzman A, Schwarz T, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Sebastiani C, Sedlaczek K, Seema P, Seidel S, Seiden A, Seidlitz B, Seitz C, Seixas J, Sekhniaidze G, Sekula S, Selem L, Semprini-Cesari N, Sengupta D, Senthilkumar V, Serin L, Serkin L, Sessa M, Severini H, Sforza F, Sfyrla A, Shabalina E, Shaheen R, Shahinian J, Renous DS, Shan L, Shapiro M, Sharma A, Sharma A, Sharma P, Sharma S, Shatalov P, Shaw K, Shaw S, Shcherbakova A, Shen Q, Sherwood P, Shi L, Shi X, Shimmin C, Shinner J, Shipsey I, Shirabe S, Shiyakova M, Shlomi J, Shochet M, Shojaii J, Shope D, Shrestha B, Shrestha S, Shrif E, Shroff M, Sicho P, Sickles A, Haddad ES, Sidoti A, Siegert F, Sijacki D, Sikora R, Sili F, Silva J, Oliveira MS, Silverstein S, Simion S, Simoniello R, Simpson E, Simpson H, Simpson L, Simpson N, Simsek S, Sindhu S, Sinervo P, Singh S, Sinha S, Sinha S, Sioli M, Siral I, Sitnikova E, Sivoklokov S, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Smakhtin V, Smart B, Smiesko J, Smirnov S, Smirnov Y, Smirnova L, Smirnova O, Smith A, Smith E, Smith H, Smith J, Smith R, Smizanska M, Smolek K, Snesarev A, Snider S, Snoek H, Snyder S, Sobie R, Soffer A, Sanchez CS, Soldatov E, Soldevila U, Solodkov A, Solomon S, Soloshenko A, Solovieva K, Solovyanov O, Solovyev V, Sommer P, Sonay A, Song W, Sonneveld J, Sopczak A, Sopio A, Sopkova F, Sothilingam V, Sottocornola S, Soualah R, Soumaimi Z, South D, Soybelman N, Spagnolo S, Spalla M, Sperlich D, Spigo G, Spinali S, Spiteri D, Spousta M, Staats E, Stabile A, Stamen R, Stampekis A, Standke M, Stanecka E, Stange M, Stanislaus B, Stanitzki M, Stapf B, Starchenko E, Stark G, Stark J, Starko D, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steentoft J, Steinberg P, Stelzer B, Stelzer H, Stelzer-Chilton O, Stenzel H, Stevenson T, Stewart G, Stewart J, Stockton M, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom D, Strom L, Stroynowski R, Strubig A, Stucci S, Stugu B, Stupak J, Styles N, Su D, Su S, Su W, Su X, Sugizaki K, Sulin V, Sullivan M, Sultan D, Sultanaliyeva L, Sultansoy S, Sumida T, Sun S, Sun S, Gudnadottir OS, Sur N, Sutton M, Suzuki H, Svatos M, Swiatlowski M, Swirski T, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taffard A, Tafirout R, Vargas JT, Takeva E, Takubo Y, Talby M, Talyshev A, Tam K, Tamir N, Tanaka A, Tanaka J, Tanaka R, Tanasini M, Tao Z, Araya ST, Tapprogge S, Mohamed ATA, Tarem S, Tariq K, Tarna G, Tartarelli G, Tas P, Tasevsky M, Tassi E, Tate A, Tateno G, Tayalati Y, Taylor G, Taylor W, Teagle H, Tee A, De Lima RT, Teixeira-Dias P, Teoh J, Terashi K, Terron J, Terzo S, Testa M, Teuscher R, Thaler A, Theiner O, Themistokleous N, Theveneaux-Pelzer T, Thielmann O, Thomas D, Thomas J, Thompson E, Thompson P, Thomson E, Tian Y, Tikhomirov V, Tikhonov Y, Timoshenko S, Timoshyn D, Ting E, Tipton P, Tlou S, Tnourji A, Todome K, Todorova-Nova S, Todt S, Togawa M, Tojo J, Tokár S, Tokushuku K, Toldaiev O, Tombs R, Tomoto M, Tompkins L, Topolnicki K, Torrence E, Torres H, Pastor ET, Toscani M, Tosciri C, Tost M, Tovey D, Traeet A, Trandafir I, Trefzger T, Tricoli A, Trigger I, Trincaz-Duvoid S, Trischuk D, Trocmé B, Troncon C, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsai M, Tsiamis A, Tsiareshka P, Tsigaridas S, Tsirigotis A, Tsiskaridze V, Tskhadadze E, Tsopoulou M, Tsujikawa Y, Tsukerman I, Tsulaia V, Tsuno S, Tsur O, Tsuri K, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna A, Turchikhin S, Cakir IT, Turra R, Turtuvshin T, Tuts P, Tzamarias S, Tzanis P, Tzovara E, Ukegawa F, Poblete PU, Umaka E, Unal G, Unal M, Undrus A, Unel G, Urban J, Urquijo P, Usai G, Ushioda R, Usman M, Uysal Z, Vacavant L, Vacek V, Vachon B, Vadla K, Vafeiadis T, Vaitkus A, Valderanis C, Santurio EV, Valente M, Valentinetti S, Valero A, Moreno EV, Vallier A, Ferrer JV, Van Arneman D, Van Daalen T, Van Der Graaf A, Van Gemmeren P, Van Rijnbach M, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall E, Vannicola D, Vannoli L, Vari R, Varnes E, Varni C, Varol T, Varouchas D, Varriale L, Varvell K, Vasile M, Vaslin L, Vasquez G, Vasyukov A, Vazeille F, Schroeder TV, Veatch J, Vecchio V, Veen M, Veliscek I, Veloce L, Veloso F, Veneziano S, Ventura A, Gonzalez SV, Verbytskyi A, Verducci M, Vergis C, De Araujo MV, Verkerke W, Vermeulen J, Vernieri C, Vessella M, Vetterli M, Vgenopoulos A, Maira NV, Vickey T, Boeriu OV, Viehhauser G, Vigani L, Villa M, Perez MV, Villhauer E, Vilucchi E, Vincter M, Virdee G, Vishwakarma A, Visibile A, Vittori C, Vivarelli I, Vladimirov V, Voevodina E, Vogel F, Vokac P, Volkotrub Y, Von Ahnen J, Von Toerne E, Vormwald B, Vorobel V, Vorobev K, Vos M, Voss K, Vossebeld J, Vozak M, Vozdecky L, Vranjes N, Milosavljevic MV, Vreeswijk M, Vu N, Vuillermet R, Vujinovic O, Vukotic I, Wada S, Wagner C, Wagner J, Wagner W, Wahdan S, Wahlberg H, Wakida M, Walder J, Walker R, Walkowiak W, Wall A, Wamorkar T, Wang A, Wang C, Wang C, Wang H, Wang J, Wang RJ, Wang R, Wang R, Wang S, Wang S, Wang T, Wang W, Wang W, Wang X, Wang X, Wang X, Wang Y, Wang Y, Wang Z, Wang Z, Wang Z, Warburton A, Ward R, Warrack N, Watson A, Watson H, Watson M, Watton E, Watts G, Waugh B, Weber C, Weber H, Weber M, Weber S, Wei C, Wei Y, Weidberg A, Weik E, Weingarten J, Weirich M, Weiser C, Wells C, Wenaus T, Wendland B, Wengler T, Wenke N, Wermes N, Wessels M, Wharton A, White A, White A, White M, Whiteson D, Wickremasinghe L, Wiedenmann W, Wiel C, Wielers M, Wiglesworth C, Wilbern D, Wilkens H, Williams D, Williams H, Williams S, Willocq S, Wilson B, Windischhofer P, Winkel F, Winklmeier F, Winter B, Winter J, Wittgen M, Wobisch M, Wolffs Z, Wölker R, Wollrath J, Wolter M, Wolters H, Wongel A, Worm S, Wosiek B, Woźniak K, Wozniewski S, Wraight K, Wu C, Wu J, Wu M, Wu M, Wu S, Wu X, Wu Y, Wu Z, Wuerzinger J, Wyatt T, Wynne B, Xella S, Xia L, Xia M, Xiang J, Xie M, Xie X, Xin S, Xiong J, Xu D, Xu H, Xu L, Xu R, Xu T, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yamaguchi Y, Yamashita E, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan S, Yan Z, Yang H, Yang H, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Y, Yang Z, Yao WM, Yap Y, Ye H, Ye H, Ye J, Ye S, Ye X, Yeh Y, Yeletskikh I, Yeo B, Yexley M, Yin P, Yorita K, Younas S, Young C, Young C, Yu Y, Yuan M, Yuan R, Yue L, Zaazoua M, Zabinski B, Zaid E, Zakareishvili T, Zakharchuk N, Zambito S, Saa JZ, Zang J, Zanzi D, Zaplatilek O, Zeitnitz C, Zeng H, Zeng J, Zenger D, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zhai M, Zhang B, Zhang D, Zhang J, Zhang J, Zhang K, Zhang L, Zhang P, Zhang R, Zhang S, Zhang T, Zhang X, Zhang X, Zhang Y, Zhang Y, Zhang Z, Zhang Z, Zhao H, Zhao P, Zhao T, Zhao Y, Zhao Z, Zhemchugov A, Zheng J, Zheng K, Zheng X, Zheng Z, Zhong D, Zhou B, Zhou H, Zhou N, Zhou Y, Zhu C, Zhu J, Zhu Y, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zimine N, Zinsser J, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas T, Zormpa O, Zou W, Zwalinski L. Combination and summary of ATLAS dark matter searches interpreted in a 2HDM with a pseudo-scalar mediator using 139 fb -1 of s=13 TeV pp collision data. Sci Bull (Beijing) 2024:S2095-9273(24)00399-2. [PMID: 39179456 DOI: 10.1016/j.scib.2024.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 07/03/2023] [Accepted: 05/27/2024] [Indexed: 08/26/2024]
Abstract
Results from a wide range of searches targeting different experimental signatures with and without missing transverse momentum (ETmiss) are used to constrain a Two-Higgs-Doublet Model (2HDM) with an additional pseudo-scalar mediating the interaction between ordinary and dark matter (2HDM+a). The analyses use up to 139 fb-1 of proton-proton collision data at a centre-of-mass energy s=13 TeV recorded with the ATLAS detector at the Large Hadron Collider during 2015-2018. The results from three of the most sensitive searches are combined statistically. These searches target signatures with large ETmiss and a leptonically decaying Z boson; large ETmiss and a Higgs boson decaying to bottom quarks; and production of charged Higgs bosons in final states with top and bottom quarks, respectively. Constraints are derived for several common and new benchmark scenarios in the 2HDM+a.
Collapse
|
37
|
Xu R, Sheng R, Lin W, Jiang S, Zhang D, Liu L, Lei K, Li X, Liu Z, Zhang X, Wang Y, Seriwatanachai D, Zhou X, Yuan Q. METTL3 Modulates Ctsk + Lineage Supporting Cranial Osteogenesis via Hedgehog. J Dent Res 2024; 103:734-744. [PMID: 38752256 DOI: 10.1177/00220345241245033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/21/2024] Open
Abstract
N6-methyladenosine (m6A) modification, a eukaryotic messenger RNA modification catalyzed by methyltransferase-like 3 (METTL3), plays a pivotal role in stem cell fate determination. Calvarial bone development and maintenance are orchestrated by the cranial sutures. Cathepsin K (CTSK)-positive calvarial stem cells (CSCs) contribute to mice calvarial ossification. However, the role of m6A modification in regulating Ctsk+ lineage cells during calvarial development remains elusive. Here, we showed that METTL3 was colocalized with cranial nonosteoclastic Ctsk+ lineage cells, which were also associated with GLI1 expression. During neonatal development, depletion of Mettl3 in the Ctsk+ lineage cells delayed suture formation and decreased mineralization. During adulthood maintenance, loss of Mettl3 in the Ctsk+ lineage cells impaired calvarial bone formation, which was featured by the increased bone porosity, enhanced bone marrow cavity, and decreased number of osteocytes with the less-developed cellular outline. The analysis of methylated RNA immunoprecipitation sequencing and RNA sequencing data indicated that loss of METTL3 reduced Hedgehog (Hh) signaling pathway. Restoration of Hh signaling pathway by crossing Sufufl/+ alleles or by local administration of SAG21 partially rescued the abnormity. Our data indicate that METTL3 modulates Ctsk+ lineage cells supporting calvarial bone formation by regulating the Hh signaling pathway, providing new insights for clinical treatment of skull vault osseous diseases.
Collapse
|
38
|
Zhang X, Huang LF, Hua L, Feng HK, Shen B. Retraction Note: Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2024; 28:3809. [PMID: 38946391 DOI: 10.26355/eurrev_202407_36455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 07/02/2024]
Abstract
The article "Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway", by X. Zhang, L.-F. Huang, L. Hua, H.-K. Feng, B. Shen, published in Eur Rev Med Pharmacol Sci 2019; 23 (4): 1789-1796-DOI: 10.26355/eurrev_201902_17142-PMID: 30840305 has been retracted by the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/6A6E686494A160FBE7A1725E5CE30C) regarding figure duplication in Figures 1 and 2A, the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal investigation revealed a figure duplication between the panels AMI and AMI+RSV+LY of Figure 1. The authors were informed about the journal's investigation but remained unresponsive and did not provide the study's raw data. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17142.
Collapse
|
39
|
Xu X, Zhang C, Yin J, Smajic J, Bahabri M, Lei Y, Hedhili MN, Hota MK, Shi L, Guo T, Zheng D, El-Demellawi JK, Lanza M, Costa PMFJ, Bakr OM, Mohammed OF, Zhang X, Alshareef HN. Correction to "Anisotropic Superconducting Nb 2CT x MXene Processed by Atomic Exchange at the Wafer Scale". ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2024; 36:e2405648. [PMID: 38767496 DOI: 10.1002/adma.202405648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2024]
|
40
|
Foley EL, Levinton FM, Uzun-Kaymak IU, Galante ME, Zhang X. The motional Stark effect diagnostic for ITER. THE REVIEW OF SCIENTIFIC INSTRUMENTS 2024; 95:073522. [PMID: 39053478 DOI: 10.1063/5.0215575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2024] [Accepted: 07/01/2024] [Indexed: 07/27/2024]
Abstract
An overview of the plans for the motional Stark effect (MSE) diagnostic installation on the International Thermonuclear Experimental Reactor (ITER) is presented. The MSE diagnostic uniquely provides spatially localized magnetic field measurements inside the plasma. These are used to constrain equilibrium reconstructions to determine q(r), the safety factor as a function of minor radius. Meeting the system requirements to deliver q-profiles and related quantities with the specified radial resolution of 20 points over the minor radius, 10 ms time resolution, and better than 10% accuracy is challenging. MSE systems observe the D/H-α emission near 656.3 nm from neutral beams. As the beam atoms traverse the magnetic field, B⃗, at high velocity, v⃗, they experience a Lorentz electric field, v⃗×B⃗, which causes the spectral emission to be split and polarized due to the Stark effect. Traditional MSE-LP (line polarization) measurements determine the direction of the magnetic field in the observation volume using polarimetric analysis of the detected light. The harsh conditions of ITER are expected to deposit thin films of contaminants on the first mirror, which would alter the polarization state of reflected light significantly. On ITER, the combination of high magnetic field strength and high energy beams makes the Stark spectrum resolution suitable for the determination of the magnetic field magnitude from the line shift, so this approach has been selected. Every aspect of the measurement system must be planned for the burning plasma environment and carefully analyzed ahead of time. Current status and plans for the system are presented.
Collapse
|
41
|
Ning F, Du L, Li J, Wu T, Zhou J, Chen Z, Hu X, Zhang Y, Luan X, Xin H, Yuan C, Zhang X. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1. Life Sci 2024; 348:122674. [PMID: 38692507 DOI: 10.1016/j.lfs.2024.122674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 04/21/2024] [Accepted: 04/26/2024] [Indexed: 05/03/2024]
Abstract
AIMS Ubiquitin specific peptidase 5 (USP5), a member of deubiquitinating enzymes, has garnered significant attention for its crucial role in cancer progression. This study aims to explore the role of USP5 and its potential molecular mechanisms in cholangiocarcinoma (CCA). MAIN METHODS To explore the effect of USP5 on CCA, gain-of-function and loss-of-function assays were conducted in human CCA cell lines RBE and HCCC9810. The CCK8, colony-forming assay, EDU, flow cytometry, transwell assay and xenografts were used to assess cell proliferation, migration and tumorigenesis. Western blot and immunohistochemistry were performed to measure the expression of related proteins. Immunoprecipitation and immunofluorescence were applied to identify the interaction between USP5 and Y box-binding protein 1 (YBX1). Ubiquitination assays and cycloheximide chase assays were carried out to confirm the effect of USP5 on YBX1. KEY FINDINGS We found USP5 is highly expressed in CCA tissues, and upregulated USP5 is required for the cancer progression. Knockdown of USP5 inhibited cell proliferation, migration and epithelial-mesenchymal transition (EMT) in vitro, along with suppressed xenograft tumor growth and metastasis in vivo. Mechanistically, USP5 could interact with YBX1 and stabilize YBX1 by deubiquitination in CCA cells. Additionally, silencing of USP5 hindered the phosphorylation of YBX1 at serine 102 and its subsequent translocation to the nucleus. Notably, the effect induced by USP5 overexpression in CCA cells was reversed by YBX1 silencing. SIGNIFICANCE Our findings reveal that USP5 is required for cell proliferation, migration and EMT in CCA by stabilizing YBX1, suggesting USP5-YBX1 axis as a promising therapeutic target for CCA.
Collapse
|
42
|
Zhang X, Ma L, Liu X, Cui N, Guo B, Zhang L. Association between health insurance programs and rehabilitation services utilisation among people with disabilities: evidence from China. Public Health 2024; 232:201-207. [PMID: 38815542 DOI: 10.1016/j.puhe.2024.04.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2023] [Revised: 04/04/2024] [Accepted: 04/16/2024] [Indexed: 06/01/2024]
Abstract
OBJECTIVES Rehabilitation is crucial to improve the health status of people with disabilities. Previous studies mainly analysed the impact of health insurance on utilisation of general health services; the relationship between health insurances and rehabilitation services utilisation among Chinese people with disabilities has been long neglected. This study aimed to analyse the association between health insurance programs and rehabilitation services utilisation among disabled people. STUDY DESIGN This was a cross-sectional study. METHODS The data used in this study were derived from 2021 National Household Income Survey of Disabled People and National Basic Database of People with Disabilities conducted by China Disabled Persons' Federation. Logistic regression model was used to analyse the relationship between health insurance and rehabilitation services utilisation, and the propensity score matching method was used to check the robustness of the results. RESULTS (1) Disabled people insured by the Basic Medical Insurance System for Urban Employees (BMISUE) and the Basic Medical Insurance System for Urban and Rural Residents (BMISURR) were positively associated with rehabilitation service utilisation (odds ratio [OR] = 1.852, 95% confidence interval [CI]:1.268, 2.707; OR = 1.375, 95% CI: 0.962, 1.966). (2) The utilisation level of rehabilitation service among disabled people insured by BMISUE was significantly higher than those insured by BMISURR (OR = 1.355, 95% CI: 1.161, 1.581). (3) The supply of rehabilitation services at the community level was positively correlated with the utilisation by people with disabilities. CONCLUSION Health insurance can improve the financial accessibility of using rehabilitation services, and the utilisation level will increase as the benefits level of health insurance increase.
Collapse
|
43
|
Tang SH, Min J, Zhang X, Uwah E, Griffis HM, Cielo CM, Fiks AG, Mindell JA, Tapia IE, Williamson AA. Incidence of pediatric narcolepsy diagnosis and management: evidence from claims data. J Clin Sleep Med 2024; 20:1141-1151. [PMID: 38450539 PMCID: PMC11217630 DOI: 10.5664/jcsm.11104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 02/27/2024] [Accepted: 02/27/2024] [Indexed: 03/08/2024]
Abstract
STUDY OBJECTIVES The purpose of this study was to characterize the incidence of pediatric narcolepsy diagnosis, subsequent care, and potential sociodemographic disparities in a large US claims database. METHODS Merative MarketScan insurance claims (n = 12,394,902) were used to identify youth (6-17 years of age) newly diagnosed with narcolepsy (International Classification of Diseases, 10th revision codes). Narcolepsy diagnosis and care 1 year postdiagnosis included polysomnography with Multiple Sleep Latency Test, pharmacological care, and clinical visits. Potential disparities were examined by insurance coverage and child race and ethnicity (Medicaid-insured only). RESULTS The incidence of narcolepsy diagnosis was 10:100,000, primarily type 2 (69.9%). Most diagnoses occurred in adolescents with no sex differences, but higher rates in Black vs White youth with Medicaid. Two thirds had a prior sleep disorder diagnosis and 21-36% had other co-occurring diagnoses. Only half (46.6%) had polysomnography with Multiple Sleep Latency Test (± 1 year postdiagnosis). Specialty care (18.9% pulmonary, 26.9% neurology) and behavioral health visits were rare (34.4%), although half were prescribed stimulant medications (51.0%). Medicaid-insured were 86% less likely than commercially insured youth to have any clinical care and 33% less likely to have polysomnography with Multiple Sleep Latency Test. CONCLUSIONS Narcolepsy diagnoses occurred in 0.01% of youth, primarily during adolescence, and at higher rates for Black vs White children with Medicaid. Only half overall had evidence of a diagnostically required polysomnography with Multiple Sleep Latency Test, underscoring potential misdiagnosis. Many patients had co-occurring conditions, but specialty and behavioral health care were limited. Results suggest misdiagnosis, underdiagnosis, and limited narcolepsy treatment, as well as possible disparities. Results highlight the need to identify determinants of evidence-based pediatric narcolepsy diagnosis and management. CITATION Tang SH, Min J, Zhang X, et al. Incidence of pediatric narcolepsy diagnosis and management: evidence from claims data. J Clin Sleep Med. 2024;20(7):1141-1151.
Collapse
|
44
|
Duan LH, Li LI, Wang CB, Liu QQ, Zhang X, Wu ZZ. Brain targeting efficacy of novel drug delivery system in the treatment of Alzheimer's disease. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2024; 28:3892-3904. [PMID: 39012229 DOI: 10.26355/eurrev_202407_36521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/17/2024]
Abstract
OBJECTIVE Alzheimer's disease (AD), a common degenerative disease of the central nervous system in the elderly, has become the third largest health killer after cardiovascular and cerebrovascular diseases and tumors. Based on the fact that Alzheimer's disease is a disease with multiple etiologies and complex pathology, a single target is bound to have a limited curative effect, and the synergy of multiple links and multiple targets is expected to achieve a better curative effect. The aim of this study is to investigate the brain targeting of a drug modified by chitosan, based on the new nanodrug delivery system for treating Alzheimer's disease developed by the research group. MATERIALS AND METHODS Chitosan with good biocompatibility, biosorption, and degradation products that can protect and promote the regeneration of nerve cells was selected to combine with galantamine, a natural representative cholinesterase inhibitor, to develop a new nano drug delivery system for nasal delivery of anti-Alzheimer's disease with a multi-target synergistic effect. Synchronous analysis was conducted on the blood and brain tissue drug concentrations after intravenous and nasal administration of the original drug solution and system solution. The brain targeting index (DTI) is used to evaluate the brain targeting effect of the nano-drug delivery system after intranasal administration. RESULTS The blood concentration of galantamine original drug solution and galantamine system solution after intravenous injection and nasal show that in the two administration methods of intravenous injection and nasal administration, under the same administration method, the time point of the system reaching the highest blood drug concentration is much higher than that of the original drug. The content of galantamine in plasma samples and tissue samples indicate that after intravenous administration and intranasal administration of the galantamine system, at the same time point, the drug concentration in brain tissue was far greater than that of the original drug of galantamine, and the duration was also longer. The concentration of drugs in brain tissue decreased gradually in the order of olfactory bulb, olfactory tract, brain, and cerebellum. In the brain tissues of the olfactory bulb, olfactory tract, cerebrum, and cerebellum, the drug concentration of the galantamine system after intravenous injection is lower than that after nasal administration. CONCLUSIONS This study concludes that compared with the original drug solution, the nano drug delivery system has significant brain targeting for nasal administration, and intravenous injection also has brain targeting. In the olfactory bulb, olfactory tract, brain, and cerebellum, the brain targeting index at the olfactory bulb is the highest, and the targeting is the best.
Collapse
|
45
|
Williamson AA, Uwah EA, Min J, Zhang X, Griffis H, Cielo CM, Tapia IE, Fiks AG, Mindell JA. Diagnosis of sleep disorders in child healthcare settings. Sleep Med 2024; 119:80-87. [PMID: 38657437 PMCID: PMC11180578 DOI: 10.1016/j.sleep.2024.04.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 04/16/2024] [Accepted: 04/17/2024] [Indexed: 04/26/2024]
Abstract
OBJECTIVES Sleep disorders impact at least 10 % of children, pose risks to overall wellbeing, and are key targets of preventive interventions. The objectives of this study were to describe the prevalence of pediatric sleep disorder diagnoses across sociodemographic characteristics and co-occurring conditions, and to explore potential sociodemographic disparities. METHODS Cross-sectional analysis of 12,394,902 children (0-17 years; 50.9 % Medicaid-insured) in the 2017 MarketScan database. Prevalence was assessed utilizing ICD-10 codes, with multivariate logistic regressions examining disparities (insurance coverage; race and ethnicity in Medicaid-insured) for diagnoses in ≥0.10 % of children. RESULTS The prevalence of sleep disorder diagnoses was 2.36 %. The most common diagnoses were obstructive sleep disordered breathing (oSDB, 1.17 %), unspecified sleep disorders (0.64 %), insomnia (0.52 %), and other SDB (0.10 %), with <0.10 % for all other diagnoses. Insomnia and parasomnias diagnoses were much lower than diagnostic estimates. Sleep diagnoses were more prevalent in Medicaid versus commercially insured youth, 2-5-year-olds, and in children with co-occurring medical, neurodevelopmental, or behavioral health conditions. Girls and boys were generally equally likely to be diagnosed with any sleep disorder. In Medicaid-insured children, white children were more likely to have any sleep diagnosis compared to all other racial and ethnic groups. Black/African American children were more likely than white children to have oSDB. CONCLUSIONS Compared to diagnostic estimates, claims data suggest sleep disorders are under-diagnosed, with notable sociodemographic disparities. Findings suggest a need for clinical resources to identify and address sleep disorders and to understand biases potentially driving disparities, given that sleep is a modifiable determinant of child wellbeing.
Collapse
|
46
|
Han J, Wang QJ, Wang CH, Li ZH, Bai RH, Zhang X, Liu JG. [A study of the correlation between gray matter atrophy in multiple sclerosis and impairment of cognitive function domains]. ZHONGHUA NEI KE ZA ZHI 2024; 63:666-673. [PMID: 38951090 DOI: 10.3760/cma.j.cn112138-20231129-00350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 07/03/2024]
Abstract
Objective: To quantify cerebral cortical and deep gray matter atrophy in patients with multiple sclerosis (MS) and explore its correlation with impairment in domains of cognitive function. Methods: Twenty patients with MS and 16 healthy controls (HC) matched for age, sex, and education level were included. Using FreeSurfer software, based on 3D-MRI technology, the differences in cortical thickness and deep gray matter volume between the two groups were comparatively analyzed. A neuropsychological scale that included six domains of cognitive function was scored on both study groups to analyze the correlation between cortical thickness and volume of deep gray matter in MS patients with impairment in cognitive function domains. Results: Impairment in domains of cognitive function: cognitive impairment was present in 60% MS patients in this study, mainly manifesting as impairment of verbal memory, verbal fluency, visuospatial memory, and information processing speed function (all P<0.05). Of these, the majority had impaired visuospatial memory function (55.0%), and the least number of patients had impaired information processing speed (15.0%). Changes in cortical thickness: compared with the HC group, the MS group showed that cortical atrophy was mainly concentrated in the frontoparietal region, including significant thinning of cortical thickness in the left inferior parietal gyrus, right superior frontal gyrus, and the right superior parietal gyrus (all P<0.05). Among them, atrophy of the left inferior parietal gyrus was significantly positively correlated with the impairment of verbal memory, verbal fluency, and information processing speed (all P<0.05). There was a significant positive correlation between the right superior frontal gyrus atrophy and verbal memory, verbal fluency, and visuospatial memory impairment (all P<0.05). Changes in deep gray matter volume: compared with the HC group, deep gray matter volume in the MS group decreased significantly in the bilateral thalamus, bilateral putamen, bilateral pallidum (all P<0.01), and right nucleus accumbens (P<0.05). Among them, left thalamus atrophy was significantly positively correlated with visuospatial memory impairment (r=0.45, P=0.046), and left putamen atrophy was both significantly positively correlated with visuospatial memory (r=0.45, P=0.047) and information processing speed impairment (r=0.50, P=0.026). Conclusions: Early structural brain changes in MS are dominated by gray matter atrophy. Deep gray matter is more prominent than cortical atrophy.
Collapse
|
47
|
Che T, Li J, Li X, Wang Z, Zhang X, Yang W, Liu T, Wang Y, Wang K, Gao T, Shen G, Qiu W, Li Z, Zhang W. Haplotype-resolved assembly of the mule duck genome using high-fidelity sequencing technology. PLoS One 2024; 19:e0305914. [PMID: 38950038 PMCID: PMC11216606 DOI: 10.1371/journal.pone.0305914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Accepted: 06/06/2024] [Indexed: 07/03/2024] Open
Abstract
Mule duck is vitally important to the production of global duck meat. Here, we present two high-quality haplotypes of a female mule duck (haplotype 1 (H1):1.28 Gb, haplotype 2 (H2): 1.40 Gb). The continuity (H1: contig N50 = 14.90 Mb, H2: contig N50 = 15.70 Mb) and completeness (BUSCO: H1 = 96.9%, H2 = 97.3%) are substantially better than those of other duck genomes. We detected the structural variations (SVs) in H1 and H2. We observed a positive correlation between autosome length and the number of SVs. Z chromosome was some deficient in deletions and insertions, but W chromosome was some excessive. A total of 1,451 genes were haplotype specific expression (HSEs). Among them, 737 specifically expressed in H1, and 714 specifically expressed in H2. We found that H1 and H2 HSEs tended to be involved in similar biological processes, such as myometrial relaxation and contraction pathways, muscle structure development and phosphorylation. Our haplotype-resolved genome assembly provides a powerful platform for future functional genomics, molecular breeding, and genome editing in mule duck.
Collapse
|
48
|
Yan R, Zhang T, Wang Y, Wang W, Sharif R, Liu J, Dong Q, Luan H, Zhang X, Li H, Guo S, Qi G, Jia P. The apple MdGA2ox7 modulates the balance between growth and stress tolerance in an anthocyanin-dependent manner. PLANT PHYSIOLOGY AND BIOCHEMISTRY : PPB 2024; 212:108707. [PMID: 38763002 DOI: 10.1016/j.plaphy.2024.108707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 04/19/2024] [Accepted: 05/05/2024] [Indexed: 05/21/2024]
Abstract
Apple (Malus domestica Borkh.) is a widely cultivated fruit crop worldwide but often suffers from abiotic stresses such as salt and cold. Gibberellic acid (GA) plays a pivotal in controlling plant development, environmental adaptability, and secondary metabolism. The GA2-oxidase (GA2ox) is responsible for the deactivation of bioactive GA. In this study, seventeen GA2-oxidase genes were identified in the apple genome, and these members could be clustered into four clades based on phylogenetic relationships and conserved domain structures. MdGA2ox7 exhibited robust expression across various tissues, responded to cold and salt treatments, and was triggered in apple fruit peels via light-induced anthocyanin accumulation. Subcellular localization prediction and experiments confirmed that MdGA2ox7 was located in the cytoplasm. Overexpression of MdGA2ox7 in Arabidopsis caused a lower level of active GA and led to GA-deficient phenotypes, such as dwarfism and delayed flowering. MdGA2ox7 alleviated cold and salt stress damage in both Arabidopsis and apple in concert with melatonin (MT). Additionally, MdGA2ox7 enhanced anthocyanin biosynthesis in apple calli and activated genes involved in anthocyanin synthesis. These findings provide new insights into the functions of apple GA2ox in regulating development, stress tolerance, and secondary metabolism.
Collapse
|
49
|
Zhang X, Chang L, Ma Q, Zhang Q, Xu W, Li Q. Comparative efficacy of immune checkpoint inhibitors versus chemotherapy alone in diffuse pleural mesothelioma. Thorac Cancer 2024; 15:1590-1597. [PMID: 38837605 PMCID: PMC11246780 DOI: 10.1111/1759-7714.15386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Revised: 04/16/2024] [Accepted: 05/08/2024] [Indexed: 06/07/2024] Open
Abstract
BACKGROUND This study aimed to investigate the effects of immune checkpoint inhibitors (ICIs) versus chemotherapy on the prognosis of real-world diffuse pleural mesothelioma patients in China. METHODS Clinical data of 90 patients with diffuse pleural mesothelioma from 2019 to 2022 were collected from Harbin Medical University Cancer Hospital. Patients were divided into two groups: the ICIs-treated group (n = 46) and the chemotherapy-only group (n = 44). The efficacy and safety of immunotherapy relative to chemotherapy at different treatment stages were explored. RESULTS The median progression-free survival (PFS) was 10.0 and 7.0 months, and the median overall survival (OS) was 24.7 and 15.8 months in the ICIs-treated group and the chemotherapy group, respectively. The ICIs-treated group showed an 11% increase in objective response rate (ORR) (52.2% vs. 41.0%) and an 8.0% increase in disease control rate (DCR) (78.3% vs. 70.0%) compared to the chemotherapy group. The Kaplan-Meier curves demonstrated significant PFS (HR: 0.61; 95% CI: 0.38-0.98; p = 0.038) and OS (HR: 0.47; 95% CI: 0.26-0.86; p = 0.011) benefits of receiving immunotherapy over chemotherapy alone. Subgroup analysis according to treatment timing showed the same trend. CONCLUSION In patients with nonsurgical diffuse pleural mesothelioma, immunotherapy achieved better survival benefits compared to chemotherapy in both first- and second-/third-line treatments. The early addition of immunotherapy improved survival in patients with nonsurgical diffuse pleural mesothelioma.
Collapse
|
50
|
Bao J, Zhang X, Xiang S, Liu H, Cheng M, Yang Y, Huang X, Xiang W, Cui W, Lai HC, Huang S, Wang Y, Qian D, Yu H. Deep Learning-Based Facial and Skeletal Transformations for Surgical Planning. J Dent Res 2024; 103:809-819. [PMID: 38808566 DOI: 10.1177/00220345241253186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2024] Open
Abstract
The increasing application of virtual surgical planning (VSP) in orthognathic surgery implies a critical need for accurate prediction of facial and skeletal shapes. The craniofacial relationship in patients with dentofacial deformities is still not understood, and transformations between facial and skeletal shapes remain a challenging task due to intricate anatomical structures and nonlinear relationships between the facial soft tissue and bones. In this study, a novel bidirectional 3-dimensional (3D) deep learning framework, named P2P-ConvGC, was developed and validated based on a large-scale data set for accurate subject-specific transformations between facial and skeletal shapes. Specifically, the 2-stage point-sampling strategy was used to generate multiple nonoverlapping point subsets to represent high-resolution facial and skeletal shapes. Facial and skeletal point subsets were separately input into the prediction system to predict the corresponding skeletal and facial point subsets via the skeletal prediction subnetwork and facial prediction subnetwork. For quantitative evaluation, the accuracy was calculated with shape errors and landmark errors between the predicted skeleton or face with corresponding ground truths. The shape error was calculated by comparing the predicted point sets with the ground truths, with P2P-ConvGC outperforming existing state-of-the-art algorithms including P2P-Net, P2P-ASNL, and P2P-Conv. The total landmark errors (Euclidean distances of craniomaxillofacial landmarks) of P2P-ConvGC in the upper skull, mandible, and facial soft tissues were 1.964 ± 0.904 mm, 2.398 ± 1.174 mm, and 2.226 ± 0.774 mm, respectively. Furthermore, the clinical feasibility of the bidirectional model was validated using a clinical cohort. The result demonstrated its prediction ability with average surface deviation errors of 0.895 ± 0.175 mm for facial prediction and 0.906 ± 0.082 mm for skeletal prediction. To conclude, our proposed model achieved good performance on the subject-specific prediction of facial and skeletal shapes and showed clinical application potential in postoperative facial prediction and VSP for orthognathic surgery.
Collapse
|